<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">79405</article-id><article-id pub-id-type="doi">10.7554/eLife.79405</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group></article-categories><title-group><article-title>Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T<sub>3</sub>) supplementation</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes" id="author-276252"><name><surname>de Assis</surname><given-names>Leonardo Vinicius Monteiro</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5209-0835</contrib-id><email>leonardo.deassis@uni-luebeck.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-277330"><name><surname>Harder</surname><given-names>Lisbeth</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="pa1">‡</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277301"><name><surname>Lacerda</surname><given-names>José Thalles</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277302"><name><surname>Parsons</surname><given-names>Rex</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277303"><name><surname>Kaehler</surname><given-names>Meike</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277304"><name><surname>Cascorbi</surname><given-names>Ingolf</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277305"><name><surname>Nagel</surname><given-names>Inga</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277306"><name><surname>Rawashdeh</surname><given-names>Oliver</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-96954"><name><surname>Mittag</surname><given-names>Jens</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-126655"><name><surname>Oster</surname><given-names>Henrik</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1414-7068</contrib-id><email>henrik.oster@uni-luebeck.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t3r8h32</institution-id><institution>Institute of Neurobiology, Center of Brain Behavior &amp; Metabolism, University of Lübeck</institution></institution-wrap><addr-line><named-content content-type="city">Lübeck</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/056d84691</institution-id><institution>Department of Medical Biochemistry and Biophysics, Karolinska Institute</institution></institution-wrap><addr-line><named-content content-type="city">Stockholm</named-content></addr-line><country>Sweden</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/036rp1748</institution-id><institution>Department of Physiology, Institute of Bioscience, University of Sāo Paulo</institution></institution-wrap><addr-line><named-content content-type="city">Sāo Paulo</named-content></addr-line><country>Brazil</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03pnv4752</institution-id><institution>Australian Centre for Health Services Innovation and Centre for Healthcare Transformation, School of Public Health and Social Work, Faculty of Health, Queensland University of Technology</institution></institution-wrap><addr-line><named-content content-type="city">Kelvin Grove</named-content></addr-line><country>Australia</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01tvm6f46</institution-id><institution>Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein</institution></institution-wrap><addr-line><named-content content-type="city">Kiel</named-content></addr-line><country>Germany</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00rqy9422</institution-id><institution>School of Biomedical Sciences, Faculty of Medicine, University of Queensland</institution></institution-wrap><addr-line><named-content content-type="city">Brisbane</named-content></addr-line><country>Australia</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t3r8h32</institution-id><institution>Center of Brain Behavior &amp; Metabolism, Institute for Endocrinology and Diabetes – Molecular Endocrinology, University of Lübeck</institution></institution-wrap><addr-line><named-content content-type="city">Lübeck</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Quinn</surname><given-names>Matthew A</given-names></name><role>Reviewing Editor</role><aff><institution>Wake Forest School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zaidi</surname><given-names>Mone</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04a9tmd77</institution-id><institution>Icahn School of Medicine at Mount Sinai</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn><fn fn-type="present-address" id="pa1"><label>‡</label><p>Division of Molecular Neurobiology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>27</day><month>07</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e79405</elocation-id><history><date date-type="received" iso-8601-date="2022-04-11"><day>11</day><month>04</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-07-25"><day>25</day><month>07</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at bioRxiv.</event-desc><date date-type="preprint" iso-8601-date="2022-04-30"><day>30</day><month>04</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.04.28.489909"/></event></pub-history><permissions><copyright-statement>© 2022, de Assis, Harder et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>de Assis, Harder et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-79405-v4.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-79405-figures-v4.pdf"/><abstract><p>Diurnal (i.e., 24 hr) physiological rhythms depend on transcriptional programs controlled by a set of circadian clock genes/proteins. Systemic factors like humoral and neuronal signals, oscillations in body temperature, and food intake align physiological circadian rhythms with external time. Thyroid hormones (THs) are major regulators of circadian clock target processes such as energy metabolism, but little is known about how fluctuations in TH levels affect the circadian coordination of tissue physiology. In this study, a high triiodothyronine (T<sub>3</sub>) state was induced in mice by supplementing T<sub>3</sub> in the drinking water, which affected body temperature, and oxygen consumption in a time-of-day-dependent manner. A 24-hr transcriptome profiling of liver tissue identified 37 robustly and time independently T<sub>3</sub>-associated transcripts as potential TH state markers in the liver. Such genes participated in xenobiotic transport, lipid and xenobiotic metabolism. We also identified 10–15% of the liver transcriptome as rhythmic in control and T<sub>3</sub> groups, but only 4% of the liver transcriptome (1033 genes) were rhythmic across both conditions – amongst these, several core clock genes. In-depth rhythm analyses showed that most changes in transcript rhythms were related to mesor (50%), followed by amplitude (10%), and phase (10%). Gene set enrichment analysis revealed TH state-dependent reorganization of metabolic processes such as lipid and glucose metabolism. At high T<sub>3</sub> levels, we observed weakening or loss of rhythmicity for transcripts associated with glucose and fatty acid metabolism, suggesting increased hepatic energy turnover. In summary, we provide evidence that tonic changes in T<sub>3</sub> levels restructure the diurnal liver metabolic transcriptome independent of local molecular circadian clocks.</p></abstract><abstract abstract-type="plain-language-summary"><title>eLife digest</title><p>Many environmental conditions, including light and temperature, vary with a daily rhythm that affects how animals interact with their surroundings. Indeed, most species have developed so-called circadian clocks: internal molecular timers that cycle approximately every 24 hours and regulate many bodily functions, including digestion, energy metabolism and sleep.</p><p>The energy metabolism of the liver – the chemical reactions that occur in the organ to produce energy from nutrients – is controlled both by the circadian clock system, and by the hormones produced by a gland in the neck called the thyroid. However, the interaction between these two regulators is poorly understood. To address this question, de Assis, Harder et al. elevated the levels of thyroid hormones in mice by adding these hormones to their drinking water.</p><p>Studying these mice showed that, although thyroid hormone levels were good indicators of how much energy mice burn in a day, they do not reflect daily fluctuations in metabolic rate faithfully. Additionally, de Assis, Harder et al. showed that elevating T<sub>3</sub>, the active form of thyroid hormone, led to a rewiring of the daily rhythms at which genes were turned on and off in the liver, affecting the daily timing of processes including fat and cholesterol metabolism. This occurred without changing the circadian clock of the liver directly.</p><p>De Assis, Harder et al.’s results indicate that time-of-day critically affects the action of thyroid hormones in the liver. This suggests that patients with hypothyroidism, who produce low levels of thyroid hormones, may benefit from considering time-of-day as a factor in disease diagnosis, therapy and, potentially, prevention. Further data on the rhythmic regulation of thyroid action in humans, including in patients with hypothyroidism, are needed to further develop this approach.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>thyroid hormones</kwd><kwd>liver</kwd><kwd>hyperthyroidism</kwd><kwd>transcriptome</kwd><kwd>circadian clock</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>353-10/1</award-id><principal-award-recipient><name><surname>Oster</surname><given-names>Henrik</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>CRC-296 &quot;LocoTact&quot; (TP14).</award-id><principal-award-recipient><name><surname>Mittag</surname><given-names>Jens</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>GRK-1957</award-id><principal-award-recipient><name><surname>Oster</surname><given-names>Henrik</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>CRC-296 &quot;LocoTact&quot;</award-id><principal-award-recipient><name><surname>Oster</surname><given-names>Henrik</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>High triiodothyronine levels lead to a broad rewiring of the liver transcriptome, which mostly occurs downstream of the liver clock machinery itself, thus suggesting that daytime critically affects thyroid hormone action in the liver.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Circadian clocks play an essential role in regulating systemic homeostasis by controlling, in a time-dependent manner, numerous biological processes that require alignment with rhythms in the environment (<xref ref-type="bibr" rid="bib10">Gerhart-Hines and Lazar, 2015</xref>; <xref ref-type="bibr" rid="bib43">West and Bechtold, 2015</xref>; <xref ref-type="bibr" rid="bib5">de Assis and Oster, 2021</xref>). At the molecular level, the clock machinery is comprised of several genes that are organized in interlocked transcriptional-translational feedback loops (TTFLs). The negative TTFL regulators, <italic>Period</italic> (<italic>Per1-3</italic>) and <italic>Cryptochrome</italic> (<italic>Cry1-2</italic>), are transcribed after activation by circadian locomotor output cycles kaput (CLOCK) and brain and muscle ARNT-like 1 (BMAL1 or ARNTL) in the subjective day. Towards the subjective night, PER and CRY proteins heterodimerize and, in the nucleus, inhibit BMAL1/CLOCK activity. This core TTFL is further stabilized by two accessory loops comprised of nuclear receptor subfamily 1 group D member 1–2 (NR1D1-2, also known as REV-ERBα-β) and nuclear receptor subfamily 1 group F member 1–3 (NR1F1-3, also known as ROR<italic>α-γ</italic>), and DBP (albumin D-site binding protein) (<xref ref-type="bibr" rid="bib39">Takahashi, 2017</xref>; <xref ref-type="bibr" rid="bib29">Pilorz et al., 2020</xref>; <xref ref-type="bibr" rid="bib5">de Assis and Oster, 2021</xref>). Upon degradation of PER/CRY, towards the end of the night, BMAL1/CLOCK are disinhibited, and a new cycle starts.</p><p>How the molecular clocks in different tissues and downstream physiological rhythms are coordinated has been the subject of increasing scientific interest in recent years. Environmental light is detected by a nonvisual retinal photoreceptive system that innervates the central circadian pacemaker, the suprachiasmatic nucleus (SCN) (<xref ref-type="bibr" rid="bib11">Golombek and Rosenstein, 2010</xref>; <xref ref-type="bibr" rid="bib16">Hughes et al., 2016</xref>; <xref ref-type="bibr" rid="bib23">Ksendzovsky et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Foster et al., 2020</xref>). The SCN distributes temporal information to other brain regions and across all organs and tissues (<xref ref-type="bibr" rid="bib17">Husse et al., 2015</xref>; <xref ref-type="bibr" rid="bib5">de Assis and Oster, 2021</xref>) through partially redundant pathways, including nervous stimuli, hormones, feeding-fasting, and body temperature cycles. Despite an ongoing discussion about the organization of systemic circadian coordination, all models share the need for robustly rhythmic systemic time cues (<xref ref-type="bibr" rid="bib5">de Assis and Oster, 2021</xref>).</p><p>The thyroid hormones (THs), triiodothyronine (T<sub>3</sub>) and thyroxine (T<sub>4</sub>), are major regulators of energy metabolism. In the liver, THs regulate cholesterol and carbohydrate metabolism, lipogenesis, and fatty acid (FA) ß-oxidation (<xref ref-type="bibr" rid="bib34">Sinha et al., 2014</xref>; <xref ref-type="bibr" rid="bib31">Ritter et al., 2020</xref>). While circadian regulation of the upstream thyroid regulator thyroid-stimulating hormone (TSH) has been described, T<sub>3</sub> and T<sub>4</sub> rhythms in the circulation show relatively modest amplitudes in mammals, probably due to their long half-life (<xref ref-type="bibr" rid="bib42">Weeke and Laurberg, 1980</xref>; <xref ref-type="bibr" rid="bib32">Russell et al., 2008</xref>; <xref ref-type="bibr" rid="bib28">Philippe and Dibner, 2015</xref>). Interestingly, in hyperthyroid patients, nonrhythmic TSH secretion patterns are observed (<xref ref-type="bibr" rid="bib18">Ikegami et al., 2019</xref>).</p><p>In this study, we investigated how a high T<sub>3</sub> state in mice affects diurnal transcriptome organization in the liver. Our data show that tonic endocrine state changes rewire the liver transcriptome in a time-dependent manner independent of the liver molecular clock. The main targets of TH signaling are the genes associated with lipid, glucose, and cholesterol metabolism.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Effects of high T<sub>3</sub> on behavioral and metabolic diurnal rhythms</title><p>We used an experimental mouse model of hyperthyroidism by supplementing the drinking water with T<sub>3</sub> (0.5 mg/L in 0.01% BSA). Control animals (CON) were kept under the same conditions with 0.01% BSA supplementation (<xref ref-type="bibr" rid="bib36">Sjögren et al., 2007</xref>; <xref ref-type="bibr" rid="bib41">Vujovic et al., 2015</xref>). TH state was validated by analyzing diurnal profiles of T<sub>3</sub> and T<sub>4</sub> levels in serum. Significant diurnal (i.e., 24 hr) rhythmicity was detected for T<sub>3</sub> in CON with peak concentrations around the dark-to-light phase transition. T<sub>3</sub>-supplemented mice showed ca. fivefold increased T<sub>3</sub> levels compared to CON mice with no significant diurnal rhythm. However, T<sub>3</sub> levels showed a temporal variation (ANOVA, p=0.006), which was classified as ultradian by JTK_CYCLE (12 hr period length, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>, p=0.01) in the T<sub>3</sub>-treated group. T<sub>4</sub> levels were nonrhythmic in all groups (<xref ref-type="fig" rid="fig1">Figure 1A, B</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Compared to CON, overall T<sub>4</sub> levels were reduced two- to threefold in T<sub>3</sub>-supplemented animals (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Resembling the human hyperthyroid condition, T<sub>3</sub> mice showed increased average body temperature (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), as well as food and water intake compared to CON mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B and C</xref>). Conversely, T<sub>3</sub> mice showed higher body weight on the third week of experimentation (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1D</xref>), as previously shown (<xref ref-type="bibr" rid="bib19">Johann et al., 2019</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Triiodothyronine (T<sub>3</sub>)-treated mice show classic effects of high thyroid hormone levels compared to control mice (CON).</title><p>(<bold>A–F</bold>) Serum levels of T<sub>3</sub> and thyroxine (T<sub>4</sub>), 24 hr profiles of locomotor activity, body temperature, O<sub>2</sub> consumption, and respiratory quotient are shown. Rhythm evaluation was performed by JTK_CYCLE (p&lt;0.01, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Presence (R) or absence of circadian rhythm (NR) is depicted. In the presence of significant 24 hr rhythmicity, a sine curve was fit. In (<bold>A</bold>) and (<bold>B</bold>), data are double plotted to emphasize the absence or presence of rhythms. (<bold>G–I</bold>) Linear regression of T<sub>3</sub> average levels with average of locomotor activity, temperature, and O<sub>2</sub> consumption. (<bold>J–O</bold>) Correlation between thyroid hormone levels and normalized levels of metabolic outputs is shown as z-scores (additional information is described in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). In (<bold>A</bold>) and (<bold>B</bold>), n = 4–6 animals per group and/or timepoint. In (<bold>C</bold>) and (<bold>D</bold>), n = 4 and 5 for CON and T<sub>3</sub> groups, respectively. In (<bold>E</bold>) and (<bold>F</bold>), n = 4 for each group.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79405-fig1-v4.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Metabolic evaluation of control (CON) and triiodothyronine (T<sub>3</sub>) mice.</title><p>(<bold>A–D</bold>) Assessment of body temperature, food and water intake (per cage, n = 8), and body weight. (<bold>E–I</bold>) Metabolic parameters (described in the y-axis) were obtained from the third week of experiment (days 19/20). Day and night data were obtained by averaging values from Zeitgeber time (ZT) 0–12 (day) and from ZT 12–24 (night) and plot accordingly. Letters represent a difference between the same group in day vs. night comparisons. Asterisks represent significant differences between CON and T<sub>3</sub> mice. In (<bold>H</bold>), 95% confidence intervals are shown. Comparison of the slope and elevations/intercept between the groups was performed: p=0.30 and 0.01, respectively. Data are shown either as mean ± SEM or by boxplot. n = 24 for (<bold>A</bold>) and (<bold>D</bold>). (<bold>E–I</bold>) n = 4–5 per group.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79405-fig1-figsupp1-v4.tif"/></fig></fig-group><p>Metabolism-associated parameters such as locomotor activity, body temperature, O<sub>2</sub> consumption (VO<sub>2</sub>), and respiratory quotient (RQ) showed significant diurnal rhythms in both conditions (<xref ref-type="fig" rid="fig1">Figure 1C–F</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). No marked differences in locomotor activity were seen between the groups (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1E</xref>). In contrast, in the T<sub>3</sub> group, body temperature was elevated in the light (rest) phase (<xref ref-type="fig" rid="fig1">Figure 1D</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1F</xref>), leading to a marked reduction in diurnal amplitude. Oxygen consumption in T<sub>3</sub> was elevated throughout the day, but this effect was more pronounced during the dark phase (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>), leading to an increase in diurnal amplitude. Linear regression of energy expenditure (EE) against body weight in CON and T<sub>3</sub> mice (<xref ref-type="bibr" rid="bib40">Tschöp et al., 2012</xref>) revealed no difference in slope, but a higher elevation/intercept was found in T<sub>3</sub> mice (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H</xref>). These data suggest that the higher EE of T<sub>3</sub> mice is not only a consequence of increased body weight, but also arises from a higher metabolic state. In T<sub>3</sub> mice, RQ was slightly higher in the second half of the dark and the beginning of the light phase, indicating higher carbohydrate utilization during this period (<xref ref-type="fig" rid="fig1">Figure 1F</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1l</xref>). In summary, TH-dependent changes in overall metabolic activity were observed resembling the human hyperthyroid condition, albeit with marked diurnal phase-specific effects.</p><p>These findings prompted us to evaluate to which extent T<sub>3</sub> and T<sub>4</sub> levels would be predictive of the overall metabolic state (<italic>TH state effects</italic>) or, alternatively, for changes in metabolic activity across the day (<italic>temporal TH effects</italic>) by correlating hormone levels with metabolic parameters. Correlating the average levels of T<sub>3</sub> against activity, body temperature, and VO<sub>2</sub> revealed that body temperature and VO<sub>2</sub> were positively correlated with T<sub>3</sub> levels (<xref ref-type="fig" rid="fig1">Figure 1G–I</xref>). TH levels and metabolic parameters, however, did not correlate across daytime. Therefore, neither T<sub>3</sub> nor T<sub>4</sub> qualified as markers for diurnal variations in energy metabolism (<xref ref-type="fig" rid="fig1">Figure 1J–O</xref>, <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). In summary, our data suggest that T<sub>3</sub> levels are valid predictors of baseline metabolic state but fail to mirror diurnal changes in metabolic activity at, both, physiological and high T<sub>3</sub> states. T<sub>4</sub> is an overall poor metabolic biomarker.</p></sec><sec id="s2-2"><title>Daytime-independent effects of TH on the liver transcriptome</title><p>To study the molecular pattern underlying the observed diurnal modulation of metabolic activity in T<sub>3</sub>-treated mice, we focused on the liver as a major metabolic tissue. We initially identified time-of-day-independent transcriptional markers reflecting TH state in this tissue. Comparing the liver transcriptome, without taking into consideration the sampling time, 2343 differentially expressed probe sets (2336 genes – DEGs) were identified (±1.5-fold change, false discovery rate [FDR] &lt;0.1, <xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Of these DEGs, 1391 and 945 genes were up- or downregulated, respectively, by elevated T<sub>3</sub> (<xref ref-type="fig" rid="fig2">Figure 2A</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). Gene set enrichment analysis (GSEA) of upregulated DEGs yielded processes related to xenobiotic metabolism/oxidation-reduction, immune system, and cholesterol metabolism, amongst others. On the other hand, GSEA of downregulated DEGs yielded biological processes pertaining to FA and carbohydrate metabolism, as well as cellular responses to insulin (<xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). We identified 37 genes whose expression was robustly up- or downregulated by T<sub>3</sub> across all timepoints (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). Genes involved in xenobiotic transport/metabolism (<italic>Abcc3</italic>, <italic>Abcg2</italic>, <italic>Ces4a</italic>, <italic>Ugt2b37</italic>, <italic>Papss2</italic>, <italic>Gstt1</italic>, <italic>Sult1d1</italic>, <italic>Cyp2d12</italic>, <italic>Ephx2</italic>, and <italic>Slc35e3</italic>), lipid, FA, and steroids metabolism (<italic>Cyp39a1</italic>, <italic>Ephx2</italic>, <italic>Akr1c18</italic>, <italic>Acnat1</italic>, <italic>Cyp4a12a/b</italic>, <italic>Cyp2c44</italic>), vitamin C transport (<italic>Slc23a1</italic>), and vitamin B<sub>2</sub> (<italic>Rfk</italic>) and glutathione metabolism (<italic>Glo1</italic>) were identified. Additional genes involved in mitosis and replication were also identified (<italic>Cep126</italic>, <italic>Mdm2, Trim24,</italic> and <italic>Mcm10</italic>) (<xref ref-type="fig" rid="fig2">Figure 2D</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Identification of daytime-independent differentially expressed genes (DEGs) in the liver of triiodothyronine (T<sub>3</sub>) mice.</title><p>(<bold>A</bold>) Global (all Zeitgeber times [ZTs] included) evaluation of liver transcriptomes revealed 2336 DEGs of which 1391 and 945 were considered as up- or downregulated, respectively, using a false discovery rate (FDR) &lt; 0.1. Genes with an FDR &lt;0.1 were classified as different irrespectively of fold change values. (<bold>B</bold>) Top 10 list of biological processes from gene set enrichment analysis (GSEA) of up- and downregulated DEGs is represented. Additional processes can be found in <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>. (<bold>C</bold>) Heatmap of liver DEGs showing significant T<sub>3</sub>-dependent regulation across all timepoints. Light and dark phases are shown as gray and black, respectively. (<bold>D</bold>) Diurnal expression profiles of most robustly regulated DEGs. Gene expression of all groups was normalized by CON mesor. Additional information is described in <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>. None of these genes showed rhythmic regulation across the day (NR). n = 4 samples per group and timepoint, except for the T<sub>3</sub> group at ZT 22 (n = 3).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79405-fig2-v4.tif"/></fig><p>We suggest that these transcripts could serve as robust daytime-independent biomarkers of TH state in the liver.</p></sec><sec id="s2-3"><title>TH-dependent regulation of liver diurnal transcriptional rhythms</title><p>We used the JTK_CYCLE algorithm (<xref ref-type="bibr" rid="bib15">Hughes et al., 2010</xref>) to describe the effects of TH state changes on 24 hr liver gene expression rhythms. We identified 3354 and 2592 probes – comprising 3329 and 2585 unique genes – as significantly rhythmic (p&lt;0.05) in CON or T<sub>3</sub>, respectively (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). Of these, 2319 and 1557 probes were classified as exclusively rhythmic in CON or T<sub>3</sub>, respectively. A total of 1035 probes (1032 genes) were identified as rhythmic in both groups (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>), amongst these most core circadian clock genes (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). Principal component analysis (PCA) showed a distinct pattern of organization across time between the groups for the shared genes (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). We next assessed the distribution of phase and amplitude across 24 hr between the groups. Rose plot analyses revealed a similar distribution pattern of phase, but T<sub>3</sub> mice showed a higher number of genes peaking in the light phase (Zeitgeber time [ZT] 7–9) and the first half of the dark phase (ZT 13–20) compared to CON (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Cross-condition comparison of genes with robust rhythmicity revealed only a minor phase advance of around 1 hr in T<sub>3</sub> (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), which was independently confirmed by qPCR (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Diurnal evaluation of liver transcriptome of triiodothyronine (T<sub>3</sub>) mice.</title><p>(<bold>A</bold>) Rhythmic probes were identified using the JTK_CYCLE algorithm (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). Venn diagram represents the distribution of rhythmic probes for each group. (<bold>B</bold>) Rose plot of all rhythmic genes from control (CON) (gray) and T<sub>3</sub> (red) are represented by the acrophase and amplitude. Phase estimation was obtained from CircaSingle algorithm. (<bold>C</bold>) Phase difference between shared rhythmic genes. Each dot represents a single gene. One-sample <italic>t</italic>-test against zero value was performed and a significant interaction (mean 0.7781, p&lt;0.001) was found. (<bold>D</bold>) Top 7 gene set enrichment analysis (GSEA) of exclusive genes from CON, T<sub>3</sub>, and shared are depicted. Additional processes are shown in <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>. (<bold>E</bold>) Sine curve was fitted for the selected clock genes. Gene expression of all groups was normalized by CON mesor. (<bold>F</bold>) For mesor, amplitude, and phase delta assessment, CircaCompare algorithm was used. The CON group was used as baseline. Additional genes (<italic>Per3</italic>, <italic>Rorc</italic>, <italic>Tef</italic>, <italic>Hif1a</italic>, and <italic>Nfil3</italic>) were used for these analyses. One-sample <italic>t</italic>-test against zero value was used and only phase was different from zero (mean 1.036, p&lt;0.001). n = 4 samples per group and timepoint, except for the T<sub>3</sub> group at Zeitgeber time (ZT) 22 (n = 3).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79405-fig3-v4.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Principal component analysis (PCA) plots of shared rhythmic genes.</title><p>Each timepoint was averaged into a single replicate, and PCA were performed using the factoextra package in R and Hartigan-Wong, Lloyd, and Forgy MacQueen algorithms.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79405-fig3-figsupp1-v4.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Validation of clock gene diurnal profile by qPCR.</title><p>CircaCompare was used to evaluate the difference in rhythmic parameters, and one-sample <italic>t</italic>-test against zero value was performed (mean 0.9069 hr, p=0.0221). Sine curve was fitted for rhythmic genes (R). n = 3–4 samples per group and timepoint.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79405-fig3-figsupp2-v4.tif"/></fig></fig-group><p>GSEA of rhythmic genes was performed to detect rhythmically regulated pathways under both TH conditions. In CON mice, transport, RNA splicing, lipid and glucose metabolism, and oxidation-reduction processes were overrepresented. In the high T<sub>3</sub> condition, several immune-related processes, FA oxidation, and regulation of mitogen-activated protein kinase 1 (MAPK) signaling were found. Interestingly, robustly rhythmic genes were enriched for lipid and cholesterol metabolism and circadian-related processes, suggesting that these processes are tightly coupled to circadian core clock regulation (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>). Individual inspection of clock genes revealed the absence of marked effects on mesor (i.e., the midline statistic of the diurnal rhythm sine fit) and amplitude but a slight phase advance (<xref ref-type="fig" rid="fig3">Figure 3E–F</xref>), which corroborates the phase advance effects seen at the rhythmic transcriptome level (<xref ref-type="fig" rid="fig3">Figure 3C</xref>).</p><p>We next focused on the diurnal regulation of TH signaling by analyzing the expression of genes encoding for modulators of TH signaling, that is, TH transporters, deiodinases, and TH receptors, and established TH target genes. We found that the TH transporter genes, <italic>Slc16a2</italic> (<italic>Mct8</italic>), <italic>Slc7a8</italic> (<italic>Lat2</italic>), and <italic>Slc10a1</italic> (<italic>Ntcp</italic>), lost rhythmicity in T<sub>3</sub> mice compared to CON. Amongst the receptors, <italic>Thra</italic> was rhythmic, while <italic>Thrb</italic> was arrhythmic under both conditions. Of the deiodinases, only <italic>Dio1</italic> was robustly expressed under both conditions, but without variation across the day (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Significant but nonuniform changes in baseline expression levels were observed for <italic>Slc16a10</italic>, <italic>Slc7a8</italic>, <italic>Dio1</italic> (up in T<sub>3</sub>) and <italic>Slco1a1</italic>, <italic>Thra</italic>, and <italic>Thrb</italic> (down in T<sub>3</sub>, <xref ref-type="fig" rid="fig4">Figure 4A</xref>). To analyze the effect of such changes on TH action, we studied diurnal regulation of established liver TH output genes. Reflecting elevated T<sub>3</sub>, all selected TH target genes showed increased expression across the day in T<sub>3</sub> mice (<xref ref-type="fig" rid="fig4">Figure 4B, C</xref>). No clear regulation was seen regarding amplitude or phase (<xref ref-type="fig" rid="fig4">Figure 4C</xref>).</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Gene expression evaluation of thyroid hormone (TH) regulators and metabolic outputs in triiodothyronine (T<sub>3</sub>) compared to control (CON).</title><p>(<bold>A, B</bold>) Genes involved in TH regulation, including transporters, <italic>Dio1</italic>, TH receptors, and well-known T<sub>3</sub> outputs are presented. Presence (R) or absence of circadian rhythm (NR) detected by CircaCompare is depicted. Sine curve was fitted for rhythmic genes. Gene expression of all groups was normalized by CON mesor. (<bold>C</bold>) Evaluation of rhythmic parameters from genes described in (<bold>B</bold>) was performed by CircaCompare using CON group as baseline. One-sample <italic>t</italic>-test against zero value was used and only mesor was different from zero (mean 1.371, p&lt;0.01). n = 4 samples per group and timepoint, except for the T<sub>3</sub> group at Zeitgeber time (ZT) 22 (n = 3).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79405-fig4-v4.tif"/></fig><p>In summary, we provide evidence that the molecular clock of the liver functions independent of TH state. At the same time, changes in diurnal expression patterns were found for FA oxidation- and immune system-related genes in T<sub>3</sub> mice. These changes were associated with marked gene expression profile alterations for TH signal regulators and outputs. Collectivity, these data indicate an adaptation of the diurnal liver transcriptome in response to changes in TH state in a largely tissue clock-independent manner.</p></sec><sec id="s2-4"><title>Quantitative characterization of TH-dependent changes in liver diurnal transcriptome rhythms</title><p>To dissect TH state-dependent rhythm alterations in the liver transcriptome, we employed CircaCompare (<xref ref-type="bibr" rid="bib27">Parsons et al., 2020</xref>) to assess mesor and amplitude in genes that were rhythmic in at least one condition. For precise phase estimation, analyses were performed only on robustly rhythmic genes. Of note, some differences in rhythm classification between JTK_CYCLE and CircaCompare were detected, which is expected due to the different statistical methods. Since we used CircaCompare’s rhythm parameter estimations for quantitative comparisons, gene rhythmicity cutoffs in the following analyses were taken from this algorithm. Pairwise comparisons of rhythm parameters (i.e., mesor, amplitude, and phase) revealed predominant effects of TH state on mesor (2519 probes/2504 genes) followed by alterations in amplitude (518 probes/516 genes) and phase (491 probes/genes, <xref ref-type="fig" rid="fig5">Figure 5A</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>CircaCompare analyses of triiodothyronine (T<sub>3</sub>) (red) mice compared to control (CON) (black).</title><p>(<bold>A</bold>) Venn diagram demonstrates the number of probes that displayed differences in each rhythmic parameter (mesor, amplitude, and phase). (<bold>B</bold>) Top 5 enriched biological processes for each rhythmic parameter category. (<bold>C</bold>) Summary of the CircaCompare analyses regarding glucose and fatty acid (FA) metabolism. (<bold>D, E</bold>) Representation of glucose and FA metabolism biological processes obtained from transcriptome data. (<bold>F</bold>) Diurnal rhythm evaluation of liver triacylglyceride (TAG) and day (Zeitgeber time [ZT] 2–6) vs. night (ZT18–22) serum TAG levels comparisons. (<bold>G</bold>) Summary of the CircaCompare analyses regarding cholesterol metabolism. (<bold>H</bold>) Representation of cholesterol homeostasis obtained from transcriptome data. (<bold>I</bold>) Diurnal rhythm evaluation of liver and serum cholesterol. Gene expression from each biological process was averaged per ZT and plotted. The reader should refer to the text for detailed information regarding the changes found at the gene level of these processes. Sine curve was fitted for each rhythmic biological process. Individual gene expression pertaining to these processes is found in <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>. n = 4 samples per group and timepoint, except for the T<sub>3</sub> group at ZT 22 (n = 3).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79405-fig5-v4.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Expression profile of the selected genes pertaining to biological processes identified in CircaCompare.</title><p>Diurnal profile of genes from glucose (<bold>A</bold>), fatty acid (<bold>B</bold>), and cholesterol metabolism (<bold>C</bold>). Diurnal overall gene expression was normalized by CON mesor and plotted. Sine curve was fitted for rhythmic genes (R). Absence of rhythmic is represented by connected lines and NR symbol. n = 4 samples per group and timepoint, except for the T<sub>3</sub> group at Zeitgeber time (ZT) 22 (n = 3). CircaCompare data is provided in <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-79405-fig5-figsupp1-v4.tif"/></fig></fig-group><p>We further differentiated CircaCompare outcomes into mesor or amplitude elevated (UP) or reduced (DOWN) and phase delayed or advanced for subsequent GSEA. In these analyses, lipid metabolism was enriched in all categories, except for the phase advance group, which suggests a differential regulation of different gene sets related to lipid metabolism. GSEA of genes with reduced amplitude showed enrichment for FA metabolism and cholesterol biosynthesis, whereas GSEA of elevated amplitude genes showed a strong enrichment for immune system-related genes. Interestingly, genes associated with circadian processes and response to glucose were enriched in the phase delay group (<xref ref-type="fig" rid="fig5">Figure 5B</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>).</p><p>We extracted genes associated with glucose and FA metabolic pathways from KEGG and assessed rhythmic parameter alterations according to CircaCompare (<xref ref-type="fig" rid="fig5">Figure 5C and E</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). Averaged and mesor-normalized gene expression data of each gene identified by GSEA were used to identify time-of-day-dependent changes in biological processes.</p><p>Our data suggest a rhythmic pattern of glucose transport in CON mice roughly in phase with locomotor activity (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig5">Figure 5D</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). <italic>Slc2a1</italic> (<italic>Glut1</italic>) was rhythmic in both groups but showed a higher mesor in T<sub>3</sub> mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). Conversely, <italic>Slc2a2</italic> (<italic>Glut2</italic>), the main glucose transporter in the liver, was rhythmic in both groups, but it showed a reduced mesor in T<sub>3</sub> mice. Other carbohydrate-related transporters such as <italic>Slc37a3</italic> and <italic>Slc35c1</italic> gained rhythmicity and showed higher amplitude and/or mesor in T<sub>3</sub> mice. Although GLUT1’s role in the liver is minor, increased GLUT1 signaling has been associated with liver cancer and non-alcoholic steatohepatitis (<xref ref-type="bibr" rid="bib3">Chadt and Al-Hasani, 2020</xref>). CON mice, overall rhythmicity in carbohydrate metabolization transcripts, with acrophase in the dark phase, was identified, whereas in T<sub>3</sub> mice this process was arrhythmic due to a reduction in amplitude and mesor (<xref ref-type="fig" rid="fig5">Figure 5D</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). Individual gene inspection showed that glucose kinase (<italic>Gck</italic>), an important gene that encodes a protein that phosphorylates glucose, thus allowing its internal storing and <italic>Pgk1</italic>, which encodes an enzyme responsible for the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate, showed reduction in amplitude in T<sub>3</sub> mice. Loss of rhythmicity was found for <italic>Pdk4</italic>, a gene that encodes an important kinase that inhibits pyruvate dehydrogenase, and for <italic>Pdhb,</italic> an important component of pyruvate dehydrogenase complex. Reduced inhibition of the pyruvate dehydrogenase complex is known to lead to less glucose utilization via tricarboxylic acid cycle and thus it favors ß-oxidation (<xref ref-type="bibr" rid="bib47">Zhang et al., 2014b</xref>).</p><p>Absence of rhythmicity and a higher mesor for the FA biosynthesis rate-limiting gene, <italic>Fasn</italic>, was found in T<sub>3</sub> mice, despite this process not being enriched (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). We identified two subsets of genes with a different regulation at mesor level in FA metabolism (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Overall pathway analysis suggested reduced amplitudes associated with a higher mesor. Individual inspection revealed genes mainly related to unsaturated FA, especially with biosynthesis (<italic>Fads2</italic>), and long-chain FA elongation (<italic>Elovl3</italic>, <italic>Acnat1-2</italic>, and <italic>Elovl6</italic>), and oxidation (<italic>Acox2</italic>). <italic>Fads2</italic>, <italic>Elovl2</italic>, and <italic>Elovl3</italic> genes also showed a phase delay. Other subsets of genes showed reduced mesor without changes in amplitude, amongst these genes involved in FA biosynthesis (<italic>Acsm3, Acsm5, Slc27a2</italic>, and <italic>Slc27a5</italic>), ß-oxidation (<italic>Acaa2</italic>, <italic>Hsd17b4</italic>, <italic>Crot</italic>, <italic>Acadl, Acadm, Hadh, Decr1, Cpt1a, Acsl1,</italic> and <italic>Hadhb</italic>), glycerolipids biosynthesis (<italic>Gpat4</italic>), and FA elongation (<italic>Hacd3</italic>) (<xref ref-type="fig" rid="fig5">Figure 5E</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). To evaluate the metabolic consequences of T<sub>3</sub>-mediated diurnal rewiring of FA-related transcripts, we measured triacylglyceride (TAG) levels in the liver across the day. TAG levels were rhythmic with an acrophase in the light phase in both groups. However, high T<sub>3</sub> levels resulted in a marked increase in amplitude and mesor, thus arguing for a pronounced TAG biosynthesis in the light phase, followed by a stronger reduction in the dark phase, which points to higher TAG consumption. Interestingly, in serum, TAG levels were reduced only in the night phase, likely as a result of the higher energy demands of T<sub>3</sub> mice (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, <xref ref-type="fig" rid="fig5">Figure 5F</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). Taken altogether, our data suggest a preferential effect of T<sub>3</sub> to increase FA biosynthesis and oxidation and a reduction in glucose metabolization as an energy source in the liver.</p><p>A marked diurnal transcription rhythm was observed for cholesterol metabolism genes in CON mice (<xref ref-type="fig" rid="fig5">Figure 5G and H</xref>). In T<sub>3</sub> mice, cholesterol biosynthesis-associated genes were enriched in the amplitude down group, thus suggesting a weakening of rhythmicity. Within this line, the rate-limiting enzyme-encoding gene, <italic>Hmgcr</italic>, showed loss of rhythmicity with reduced amplitude and increased mesor in T<sub>3</sub> mice (<xref ref-type="fig" rid="fig5">Figure 5H</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). Interestingly, upon evaluation of liver cholesterol levels no significant difference was observed, although in both groups, cholesterol levels were rhythmic and with an acrophase in the rest phase. In serum, only in T<sub>3</sub> mice cholesterol levels were rhythmic but showed a marked mesor reduction compared to CON, especially in the dark phase (<xref ref-type="fig" rid="fig5">Figure 5I</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>). Rhythmic genes with a marked higher mesor involved in cholesterol uptake (<italic>Ldlr</italic>, <italic>Lrp5</italic>, and <italic>Nr1h2</italic>) and secretion (<italic>Abcg5</italic>/8 and <italic>Cyp7a1</italic>) in bile acids (<xref ref-type="fig" rid="fig5">Figure 5G–I</xref>, <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>, <xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>) were detected in line with T<sub>3</sub>-mediated increased bile acid production (<xref ref-type="bibr" rid="bib9">Gebhard and Prigge, 1992</xref>; <xref ref-type="bibr" rid="bib2">Bonde et al., 2012</xref>). Taken altogether, our data suggest T<sub>3</sub>-mediated time-restricted reduction in cholesterol serum levels in favor of increased cholesterol metabolization.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we analyzed the effects of high T<sub>3</sub> state in the mouse liver. Our data argue that T<sub>3</sub> is a marker for time-independent metabolic output that is subject to distinct temporal (i.e., diurnal) modulation. At the transcriptome level, T<sub>3</sub> induction led to metabolic pathway rewiring associated with only a minor impact on the circadian clock machinery of the liver.</p><p>In the human hyperthyroidism condition, T<sub>3</sub> and T<sub>4</sub> serum levels are both elevated while TSH levels are reduced as part of the inhibitory feedback mechanism of T<sub>3</sub> on TSH secretion. In our experimental model, providing T<sub>3</sub> levels in the drinking water resulted in the activation of TH effects in the liver, but T<sub>4</sub> levels – and, likely, TSH – were reduced, as had previously been reported for this experimental model (<xref ref-type="bibr" rid="bib19">Johann et al., 2019</xref>). Again, this effect is easily explained by the negative feedback of T<sub>3</sub> on TSH – and, subsequently, T<sub>4</sub> – regulation. Based on this, we refer to our model as ‘T<sub>3</sub> high’ instead of hyperthyroid.</p><p>Another difference between our experimental model and human hyperthyroidism is an increase in body weight in response to T<sub>3</sub> treatment. In fact, some discrepancies between clinical features of hypo- and hyperthyroidism with mouse experimental model for these conditions have been reported (<xref ref-type="bibr" rid="bib19">Johann et al., 2019</xref>; <xref ref-type="bibr" rid="bib21">Kaspari et al., 2020</xref>). In the hypothyroid mouse model, decreased food intake associated with increased EE to maintain core body temperature results in a leaner phenotype (<xref ref-type="bibr" rid="bib21">Kaspari et al., 2020</xref>). For the hyperthyroidism model, although no experimental study has evaluated this discrepancy, it was argued that T<sub>3</sub> increases growth hormone biosynthesis promoting higher body weight (<xref ref-type="bibr" rid="bib1">Bargi-Souza et al., 2017</xref>).</p><p>Upon analyzing the diurnal metabolic effects of T<sub>3</sub>, we identified a reduction in core body temperature amplitude due to an elevation in the light phase. Conversely, T<sub>3</sub> mice showed a higher O<sub>2</sub> consumption amplitude due to increased respiratory activity in the dark phase. Day vs. night analyses confirmed that during the light phase T<sub>3</sub> mice have increase metabolic output, which become higher during the dark phase. The absence of an effect in locomotor activity between the groups reinforces the fact of T<sub>3</sub> as a strong activator of energy metabolism in our study, which is support by experimental data (<xref ref-type="bibr" rid="bib24">Lanni et al., 2005</xref>; <xref ref-type="bibr" rid="bib4">Cioffi et al., 2010</xref>; <xref ref-type="bibr" rid="bib26">Mullur et al., 2014</xref>; <xref ref-type="bibr" rid="bib20">Jonas et al., 2015</xref>). Thus, one could suggest that several adaptive mechanisms must happen to increase basal metabolic rate. In this line, increased energy output shown by T<sub>3</sub> mice seems to rely on a slightly increased glucose (higher RQ quotient) consumption both at light and dark phases. In the liver, our transcriptome analyses revealed important changes in gene expression reflecting increased metabolic output, which will be discussed below.</p><p>Although daytime-specific effects in metabolic outputs were observed, no clear correlation between TH levels and metabolic outputs was found, thus ruling out that T<sub>3</sub> or T<sub>4</sub> are useful <italic>temporal</italic> markers for metabolic output. On the other hand, as a <italic>state</italic> marker, that is, when seen from a longer perspective, T<sub>3</sub> served as a robust predictor of metabolic output. For T<sub>4</sub>, a lack of temporal correlation is easily explained by the absence of diurnal rhythmicity in both normal and high T<sub>3</sub> conditions. Conversely, T<sub>3</sub> levels were circadian in CON mice.</p><p>Previous studies have suggested that serum T<sub>3</sub> shows lack of rhythmicity or, if it is present, displays rhythms of small amplitude in humans and/or mice (<xref ref-type="bibr" rid="bib42">Weeke and Laurberg, 1980</xref>; <xref ref-type="bibr" rid="bib32">Russell et al., 2008</xref>; <xref ref-type="bibr" rid="bib28">Philippe and Dibner, 2015</xref>). In our experimental conditions, CON mice displayed a stable diurnal rhythm of T<sub>3</sub>, albeit with a low amplitude. It should be mentioned, however, that T<sub>3</sub> levels showed a temporal variation by ANOVA, with a period of around 12 hr.</p><p>Nonetheless, different sets of genes were differentially expressed at different times of the day, thus suggesting time-dependent effects of T<sub>3</sub> in the liver. This is suggestive of additional underlying mechanisms that are not dependent on the oscillatory T<sub>3</sub> serum levels. We hypothesized that the liver could display increased sensitivity to T<sub>3</sub> effects likely via rhythmicity in TH transporters, <italic>Dio1</italic>, and TH receptors expression and/or activity. To illustrate this concept, our transcriptome analyses showed that the liver diurnal transcriptome has 2336 robustly regulated genes (ca. 10% of the transcriptome). Previous studies from the early 2000s using microarrays identified about 2–5% as T<sub>3</sub>-responsive genes (<xref ref-type="bibr" rid="bib6">Feng et al., 2000</xref>; <xref ref-type="bibr" rid="bib7">Flores-Morales et al., 2002</xref>). Experimental differences such as different T<sub>3</sub> levels associated with differences in statistical and significance threshold levels contribute to the differences found between our data and the previous studies. Enrichment analyses showed that elevated levels of T<sub>3</sub> were associated with oxidation-reduction and immune system-related genes, whereas a negative association was found for glucose and FA metabolism.</p><p>Focusing on comprehending time-of-day-dependent effects in the liver, we focused on the DEGs per timepoint. We identified several hundreds of DEGs across time in T<sub>3</sub> mice, thus arguing for a time-dependent effect of T<sub>3</sub> in the liver. <italic>Dio1</italic> expression is classically associated with liver thyroid state (<xref ref-type="bibr" rid="bib45">Zavacki et al., 2005</xref>). In our dataset, <italic>Dio1</italic> was differently expressed in all ZTs, except for ZT 22, an effect caused by increased variation in the CON group. This finding may reflect an increased need for T<sub>3</sub> metabolization in the liver by DIO1. Although we did not measure DIO1 activity, one could suggest that the observed <italic>Dio1</italic> mRNA upregulation reflects sensitization to a scenario where T<sub>4</sub> and T<sub>3</sub> are down- and upregulated, respectively. Indeed, DIO1’s contribution to thyroid state in the liver is critical while it has little effect on systemic TH levels (<xref ref-type="bibr" rid="bib37">Streckfuss et al., 2005</xref>). Remarkably, 37 genes were identified as time-independent DEGs, that is, displayed stable T<sub>3</sub> state-dependent expression across all timepoints, of which were 22 up- and 15 downregulated in T<sub>3</sub> mice. These genes participate in several biological processes such as xenobiotic transport/metabolism, lipid, FA metabolism, amongst others. From a translational view, we suggest that these genes could be used to evaluate the thyroid state of the liver at any given time in experimental studies. Moreover, these genes could be used to create a signature of thyroid state in the liver in different conditions and diseases.</p><p>While tonic transcriptional targets of T<sub>3</sub> have been described in tissues such as the liver, at the same time, robust diurnal regulation of modulators of TH action such as TH transporters, deiodinases, and TH receptors can be observed from high-resolution circadian studies (<xref ref-type="bibr" rid="bib46">Zhang et al., 2014a</xref>; <ext-link ext-link-type="uri" xlink:href="http://circadiomics.igb.uci.edu">http://circadiomics.igb.uci.edu</ext-link>). This prompted us to study how T<sub>3</sub> may affect the transcriptional outputs across the day using established circadian biology methods. Circadian evaluation of CON and T<sub>3</sub> livers revealed 10–15% of the liver transcriptome as rhythmic under both experimental conditions, which is in line with previous experiments (<xref ref-type="bibr" rid="bib46">Zhang et al., 2014a</xref>; <xref ref-type="bibr" rid="bib12">Greco et al., 2021</xref>). A total of 1032 genes (ca. 5% of the liver transcriptome) were robustly rhythmic under both T<sub>3</sub> conditions. Overall, the elevation of T<sub>3</sub> had a slight phase-delaying effect on these rhythmic genes, which is similar to the effects found in core circadian clock genes. In fact, the similarity in the phase delay between clock gene rhythms and those of robustly rhythmic genes suggests that the latter may indeed involve control through the liver clock. One potential mechanism could involve direct regulation of clock gene transcription by THRB. THRB binding sites are found in the promoter region of several clock genes such as <italic>Bmal1</italic>, <italic>Rev-erbα/β, Cry1/2</italic>, and <italic>Per1-3</italic> (GeneCards website, <xref ref-type="bibr" rid="bib33">Safran et al., 2010</xref>). Further experimental studies are required to test this interaction of TH and clock function.</p><p>mRNA expression of TH transporter genes, <italic>Slc16a2</italic> (<italic>Mct8</italic>), <italic>Slc7a8</italic> (<italic>Lat2</italic>), and <italic>Slc10a1</italic> (<italic>Ntcp</italic>), showed a loss of rhythmicity while no gain of rhythmicity was found for T<sub>3</sub> mice. Such loss of rhythmicity in TH transporters could represent a compensatory mechanism for the higher T<sub>3</sub> levels found across the day. The transcriptional response in TH regulators suggests a desensitization mechanism in the liver of T<sub>3</sub> mice with a downregulation of TH receptors but increased baseline expression of <italic>Dio1</italic>, <italic>Slc16a10</italic>, and <italic>Slc7a8</italic>. Collectively, these data suggest a compensatory mechanism of decreased signal responses, elevated transport, and metabolization of T<sub>3</sub> under high T<sub>3</sub> conditions at the mRNA level. However, one must consider the potential diurnal regulation of TH receptor protein levels as well as DIO1 and transporter activity to fully confirm this putative compensatory mechanism.</p><p>Regarding diurnal changes, we observed a strong effect of T<sub>3</sub> on mesor, followed by changes in amplitude and phase. Interestingly, while circadian parameter analysis revealed a strong effect of T<sub>3</sub> on liver transcriptome rhythms, this was mostly without affecting the molecular clock machinery itself. Therefore, T<sub>3</sub> effects in the liver seem to act downstream of the molecular clock through a still elusive mechanism. Considering the broad range of changes found in our study, we focused our efforts on comprehending T<sub>3</sub> effects on metabolic pathways. Our data reveal a strong T<sub>3</sub>-mediated diurnal regulation of energy metabolism, mainly related to glucose and FAs, on the mRNA level. Transcripts associated with both processes lost their rhythmicity under high T<sub>3</sub> conditions, thus becoming constant across the day. Interestingly, we found evidence that T<sub>3</sub> leads to a shift towards FA ß-oxidation over glucose utilization in the liver. T<sub>3</sub> effects in FA biosynthesis showed a preferential effect on the synthesis and oxidation of long-chain FA on the mRNA level. Confirming our predictions, livers from T<sub>3</sub> mice had higher levels of TAG during the light phase compared to CON, thus suggesting a higher TAG synthesis during the rest phase. However, during the dark phase a marked reduction in TAG serum and liver levels was observed, which suggests an important role of FA ß-oxidation as an energy source to meet the higher energetic demands imposed by T<sub>3</sub>. Indeed, such changes can be associated with higher energetic demands (higher VO<sub>2</sub>) both during the light and dark phases in T<sub>3</sub> mice. It is a known fact that T<sub>3</sub> increases TAG synthesis in the liver (<xref ref-type="bibr" rid="bib35">Sinha et al., 2018</xref>), but our data provide an interesting time of day dependency on T<sub>3</sub> effects. Interestingly, no marked alteration in protein catabolism was found, thus suggesting preferential effects of T<sub>3</sub> for glucose and FA-related energy sources, at least in the liver (<xref ref-type="bibr" rid="bib26">Mullur et al., 2014</xref>).</p><p>Our bioinformatic analyses predicted a higher pool of acetyl-CoA in the liver of T<sub>3</sub> mice as a consequence of higher FA ß-oxidation, which we hypothesized to be associated with a putative increased cholesterol biosynthesis. However, no differences were observed in liver cholesterol between the groups, but a marked reduction in serum cholesterol levels was identified in T<sub>3</sub> mice. In face of no differences in cholesterol levels in the liver, but associated with a marked reduction in serum cholesterol, we suggest a cholesterol higher uptake and conversion into bile acid. Indeed, such mechanism is supported by our transcriptomic data as well as the literature as T<sub>3</sub> is known to increase cholesterol secretion via bile acids or non-esterified cholesterol in the feces (<xref ref-type="bibr" rid="bib26">Mullur et al., 2014</xref>; <xref ref-type="bibr" rid="bib35">Sinha et al., 2018</xref>). Such marked diurnal alterations in the liver transcriptome, especially with regard to metabolic pathways, led us to speculate on the overall consequences of high T<sub>3</sub> on organismal rhythms. Loss or weakening of rhythmicity in relevant metabolic processes in other organs, such as the pancreas, white and brown adipose tissue, and other organs, may also take place in the high T<sub>3</sub> condition, which could explain the higher energetic demands induced by elevated T<sub>3</sub> levels. It is still elusive how T<sub>3</sub> affects other metabolic and nonmetabolic organs in a circadian way. Such knowledge will prove useful in designing therapeutic strategies for TH-related diseases such as hepatic steatosis (<xref ref-type="bibr" rid="bib25">Marjot et al., 2022</xref>).</p><p>Considering the effects seen in the liver circadian transcriptome, associated with the metabolic data provided, we suggest that T<sub>3</sub> may act as a rewiring factor of metabolic rhythms. In this sense, T<sub>3</sub> leads to reduction in rhythmicity of major metabolic pathways to sustain higher energy demands across the day. Such pronounced effects are not reflected in marked alterations in the liver clock. From a chronobiological perspective, T<sub>3</sub> may be considered a disruptor that uncouples the circadian clock from its outputs, thus promoting a state of chronodisruption (<xref ref-type="bibr" rid="bib30">Potter et al., 2016</xref>; <xref ref-type="bibr" rid="bib5">de Assis and Oster, 2021</xref>). This duality of T<sub>3</sub> effects warrants further investigation.</p><p>An exciting concept that arises from our data is the concept of chronomodulated regimes for thyroid-related diseases such as hypo- and hyperthyroidism. We suggest evidence that the liver and presumably other organs may show temporal windows in which treatment can be more effective. Based on our diurnal transcriptome data, no optimal time could be suggested due to the lack of rhythmicity for <italic>Dio1</italic>, <italic>Thrb</italic>, and other TH regulator genes. Nonetheless, time-dependent effects in other genes and/or biological processes were identified and could be explored for chronotherapeutic drug intervention.</p><p>Taken altogether, our study shows that T<sub>3</sub> displays time-of-day-dependent effects in metabolism output and liver transcriptome despite the presence of a strong T<sub>3</sub> diurnal rhythm. With regard to metabolism, T<sub>3</sub> acts as a <italic>state</italic> marker but fails to reflect temporal regulation of metabolic output. Metabolic changes induced by T<sub>3</sub> resulted in a higher overall activation and loss of rhythmicity of genes involved in glucose and FA metabolism, concomitant with higher metabolic turnover, and independent of the liver circadian clock. Our findings reveal a novel layer of regulation of TH action in the liver, and, potentially, in other tissues. As we have shown that high T<sub>3</sub> disrupts the rhythmicity of important metabolic processes, this implies that the time of assessment of metabolic parameters in hyperthyroid (and, similarly, hypothyroid) patients should be taken into consideration. Another novel aspect of our findings is the role of liver circadian rhythms in modulating local TH action itself. Such circadian gating might explain variances in the outcomes of T<sub>3</sub> treatment if temporal aspects are not taken into consideration. Our data strongly argue for more temporal control in TH studies. Finally, considering that THs are major regulators of metabolism in the liver, therapies of metabolic pathologies could benefit from chronomodulated regimes. Modulation of TH action has been proposed for nonalcoholic fatty liver disease treatment (<xref ref-type="bibr" rid="bib22">Kowalik et al., 2018</xref>; <xref ref-type="bibr" rid="bib48">Zhao et al., 2022</xref>), and our data may assist in the design of a time-of-day-dependent drug regime for this approach (<xref ref-type="bibr" rid="bib25">Marjot et al., 2022</xref>).</p><p>One limitation of our finding is the lack of data on the diurnal regulation of T<sub>3</sub> effects at the protein level and on enzymatic regulation. It is not unlikely that these represent additional ways by which circadian rhythms and TH action can interact. Our conclusions arise from gene expression data and, therefore, may not fully account for the full spectrum of diurnal modulation of TH action in the livers. Collectively, our data suggest a novel layer of diurnal regulation of liver metabolism that can bear fruits for future treatments of thyroid-related diseases.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Gene (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom"> C57BL/6J</td><td align="left" valign="bottom">Janvier Labs, Germany</td><td align="left" valign="bottom"> C57BL6JRj</td><td align="left" valign="bottom"> </td></tr><tr><td align="left" valign="bottom">Strain, strain background (C57BL6JRj, male)</td><td align="left" valign="bottom"> C57BL/6JRj</td><td align="left" valign="bottom"> Janvier Labs, Germany</td><td align="left" valign="bottom"/><td align="left" valign="bottom"> 2–3-month-old male</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>M. musculus</italic>)</td><td align="left" valign="bottom"> Liver and serum</td><td align="left" valign="bottom"> Collected and immediately frozen in dry ice</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"> RNA extraction</td><td align="left" valign="bottom"> TRIzol, Thermo Fisher Scientific</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"> RNA isolation</td><td align="left" valign="bottom"> RNA Miniprep kit<break/> Zymo Research</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"> cDNA synthesis</td><td align="left" valign="bottom"> High-Capacity Complementary DNA Reverse Transcription Kit, Thermo Fisher</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"> qPCR</td><td align="left" valign="bottom"> GoTaq, Promega, USA</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"> Microarray</td><td align="left" valign="bottom"> WT Plus Kit, Thermo Fisher Scientific</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom"> qPCR primers</td><td align="left" valign="bottom"> Integrated DNA Technologies (IDT)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"> Sequences are provided in the supplementary information</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom"> T<sub>3</sub> hormone</td><td align="left" valign="bottom"> T6397, Sigma-Aldrich</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom"> BSA</td><td align="left" valign="bottom"> A7906-50G, Sigma-Aldrich</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom"> T<sub>3</sub> detection kit</td><td align="left" valign="bottom"> DNOV053, NovaTec</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom"> T<sub>4</sub> detection kit</td><td align="left" valign="bottom"> EIA-1781, DRG Diagnostics</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom"> Triglycerides quantification kit</td><td align="left" valign="bottom"> MAK266, Sigma-Aldrich</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom"> Cholesterol quantification kit</td><td align="left" valign="bottom"> STA 384, Cell Biolabs</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom"> RStudio</td><td align="left" valign="bottom"> R 4.0.3</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom"> Prisma 9</td><td align="left" valign="bottom"> GraphPad</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mouse model and experimental conditions</title><p>Two- to three-month-old male C57BL/6J mice (Janvier Labs, Germany) were housed in groups of three under a 12 hr light, 12 hr dark (LD, ~300 lux) cycle at 22 ± 2°C and a relative humidity of 60 ± 5% with ad libitum access to food and water. To render mice hyperthyroid (i.e., high T<sub>3</sub> levels), the animals received 1 week of 0.01% BSA (Sigma-Aldrich, St. Louis, USA, A7906-50G) in their drinking water, followed by 2 weeks with water supplemented with T<sub>3</sub> (0.5 mg/L, Sigma-Aldrich T6397, in 0.01% of BSA). Control animals received only 0.01% BSA in the drinking water over the whole treatment period. During the treatment period, mice were monitored for body weight and rectal temperature (BAT-12, Physitemp, Clifton, USA) individually and food and water intake per cage. All in vivo experiments were ethically approved by the Animal Health and Care Committee of the Government of Schleswig-Holstein and were performed according to international guidelines on the ethical use of animals. Sample size was calculated using G-power software (version 3.1) and is shown as biological replicate in all graphs. Experiments were performed 3–4 times. Euthanasia was carried out using cervical dislocation and tissues were collected every 4 hr. Night experiments were carried out under dim red light. Tissues were immediately placed on dry ice and stored at –80°C until further processing. Blood samples were collected from the trunk, and clotting was allowed for 20 min at room temperature. Serum was obtained after centrifugation at 2500 rpm, 30 min, 4°C and samples stored at –20°C.</p></sec><sec id="s4-2"><title>Total T<sub>3</sub> and T<sub>4</sub> evaluation</title><p>Serum quantification of T<sub>3</sub> and T<sub>4</sub> was performed using commercially available kits (NovaTec, Leinfelden-Echterdingen, DNOV053, Germany, for T<sub>3</sub> and DRG Diagnostics, Marburg, EIA-1781, Germany, for T<sub>4</sub>) following the manufacturer’s instructions.</p></sec><sec id="s4-3"><title>Serum and tissue TAG and cholesterol evaluation</title><p>TAG and total cholesterol evaluation of tissue and serum were processed according to the manufacturer’s instructions (Sigma-Aldrich, MAK266 for TAG and Cell Biolabs, San Diego, USA, STA 384 for cholesterol).</p></sec><sec id="s4-4"><title>Telemetry and metabolic evaluation</title><p>Core body temperature and locomotor activity were monitored in a subset of single-housed animals using wireless transponders (E-mitters, Starr Life Sciences, Oakmont, USA). Probes were transplanted into the abdominal cavity of mice 7 days before starting the drinking water treatment. During the treatment period, mice were recorded once per week for at least two consecutive days. Recordings were registered at 1 min intervals using the Vital View software (Starr Life Sciences). Temperature and activity data were averaged over two consecutive days (treatment days: 19/20) and plotted in 60 min bins.</p><p>An open-circuit indirect calorimetry system (TSE PhenoMaster, TSE Systems, USA) was used to determine respiratory quotient (RQ = carbon dioxide produced/oxygen consumed) and EE in a subset of single-housed mice during drinking water treatment. Mice were acclimatized to the system for 1 week prior to starting the measurement. Monitoring of oxygen consumption, water intake, as well as activity took place simultaneously in 20 min bins. VO<sub>2</sub> and RQ profiles were averaged over two consecutive days (treatment days: 19/20) and plotted in 60 min bins. EE was estimated by determining the caloric equivalent according to <xref ref-type="bibr" rid="bib13">Heldmaier, 1975</xref>: heat production (mW) = (4.44 + 1.43 * RQ) * VO<sub>2</sub> (mL O<sub>2</sub>/hr). A linear regression between EE and body weight was performed to rule out a possible confounding factor of body weight (<xref ref-type="bibr" rid="bib40">Tschöp et al., 2012</xref>).</p></sec><sec id="s4-5"><title>Microarray analysis</title><p>Total RNA was extracted using TRIzol (Thermo Fisher, Waltham, USA) and the Direct-zol RNA Miniprep kit (Zymo Research, Irvine, USA) according to the manufacturer’s instructions. Genome-wide expression analyses were performed using Clariom S arrays (Thermo Fisher Scientific) using 100 ng RNA of each sample according to the manufacturer’s recommendations (WT Plus Kit, Thermo Fisher Scientific). Data was analyzed using Transcriptome Analyses Console (Thermo Fisher Scientific, version 4.0) and expressed in log<sub>2</sub> values.</p></sec><sec id="s4-6"><title>DEG analysis</title><p>To identify global DEGs, all temporal data from each group were considered and analyzed by Student’s <italic>t-</italic>test and corrected for FDRs (FDR &lt; 0.1). Up- or downregulated DEGs were considered when a threshold of 1.5-fold (0.58 in log<sub>2</sub> values) regulation was met. As multiple probes can target a single gene, we curated the data to remove ambiguous genes. To identify DEGs at specific timepoints (ZTs; ZT0 = ‘lights on’), the procedure described above for each ZT was performed separately. Time-independent DEGs were identified by finding consistent gene expression pattern across all ZTs.</p></sec><sec id="s4-7"><title>Rhythm analysis</title><p>To identify probes that showed diurnal (i.e., 24 hr) oscillations, we employed the nonparametric JTK_CYCLE algorithm (<xref ref-type="bibr" rid="bib15">Hughes et al., 2010</xref>) in the Metacycle package (<xref ref-type="bibr" rid="bib44">Wu et al., 2016</xref>) with a set period of 24 hr and an adjusted p-value (ADJ.P) cutoff of 0.05. For visualization, data were plotted in Prism 9.0 (GraphPad, USA) and a sine wave was fit with a period set at 24 hr. Rhythmic gene detection by JTK_CYLCE was evaluated by CircaSingle, a nonlinear cosinor regression included in the CircaCompare algorithm (<xref ref-type="bibr" rid="bib27">Parsons et al., 2020</xref>), largely (ca. 99%) confirming the results from JTK_CYCLE. Phase and amplitude parameter estimates from CircaSingle were used for rose plot visualizations. To directly compare rhythm parameters (mesor and amplitude) in gene expression profiles between T<sub>3</sub> and CON, CircaCompare fits were used irrespective of rhythmicity thresholds. Phase comparisons were only performed when a gene was considered rhythmic in both conditions (p&lt;0.05).</p></sec><sec id="s4-8"><title>Gene set enrichment analysis</title><p>Functional enrichment analysis of DEGs was performed using the Gene Ontology (GO) annotations for Biological Processes on the Database for Annotation, Visualization, and Integrated Discovery software (DAVID 6.8; <xref ref-type="bibr" rid="bib14">Huang et al., 2009</xref>). Processes were considered significant for a biological process containing at least five genes (gene count) and a p-value&lt;0.05. To remove the redundancy of GSEA, we applied the REVIGO algorithm (<xref ref-type="bibr" rid="bib38">Supek et al., 2011</xref>) using default conditions and a reduction of 0.5. For enrichment analyses from gene sets containing less than 100 genes, biological processes containing at least two genes were included. Overall gene expression evaluation of a given biological process was performed by normalizing each timepoint of CON and T<sub>3</sub> by CON mesor. A sine curve was plot and used for representation of significantly rhythmic profiles.</p></sec><sec id="s4-9"><title>PCA plots</title><p>For PCA, each timepoint was averaged to a single replicate and analyses were performed using the factoextra package in R and Hartigan-Wong, Lloyd, and Forgy MacQueen algorithms (version 1.0.7).</p></sec><sec id="s4-10"><title>Data handling and statistical analysis of non-bioinformatic-related experiments</title><p>Samples were only excluded upon technical failure. For temporal correlation analyses, normalized values were obtained by dividing each value by the daily group average followed by Z-score transformation. Spearman’s correlation analyses were performed between different groups of animals that underwent the same treatment. Analyses were done in Prism 9.0 (GraphPad), and a p-value of 0.05 was used to reject the null hypothesis. Data from ZT0–12 were considered as light phase and from ZT 12–24 as dark phase. Data were either averaged or summed as indicated. Temporal data between groups were analyzed by two-way ANOVA followed by Bonferroni post-test. Single timepoint data were evaluated by unpaired Student’s <italic>t</italic>-test with Welch correction or Mann–Whitney test for parametric or nonparametric samples, respectively.</p></sec><sec id="s4-11"><title>Data handling and statistical analysis of bioinformatic experiments</title><p>Statistical analyses were conducted using R 4.0.3 (R Foundation for Statistical Computing, Austria) or in Prism 9.0 (GraphPad). Rhythmicity was calculated using the JTK_CYLCE algorithm in meta2d, a function of the MetaCycle R package v.1.2.0 (<xref ref-type="bibr" rid="bib44">Wu et al., 2016</xref>). Rhythmic features were calculated and compared among multiple groups using the CircaCompare R package v.0.1.1 (<xref ref-type="bibr" rid="bib27">Parsons et al., 2020</xref>). Data visualization was performed using the ggplot2 R package v.3.3.5, eulerr R package v.6.1.1, and Prism 9.0 (GraphPad). Heatmaps were created using the Heatmapper tool (<ext-link ext-link-type="uri" xlink:href="http://www.heatmapper.ca">http://www.heatmapper.ca</ext-link>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Software, Formal analysis, Investigation, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con5"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con6"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con8"><p>Methodology, Writing – review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Writing – review and editing</p></fn><fn fn-type="con" id="con10"><p>Conceptualization, Supervision, Funding acquisition, Investigation, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Metabolic output rhythmic evaluation by JTK_CYCLE.</title></caption><media xlink:href="elife-79405-supp1-v4.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Metabolic output correlation.</title></caption><media xlink:href="elife-79405-supp2-v4.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Global differentially expressed genes (DEGs).</title></caption><media xlink:href="elife-79405-supp3-v4.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Differentially expressed genes (DEGs) per Zeitgeber time (ZT).</title></caption><media xlink:href="elife-79405-supp4-v4.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>Rhythmic evaluation by JTK_CYCLE.</title></caption><media xlink:href="elife-79405-supp5-v4.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Rhythmic analyses by CircaCompare.</title></caption><media xlink:href="elife-79405-supp6-v4.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-79405-mdarchecklist1-v4.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All experimental data was deposited in the Figshare depository (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.20376444.v1">https://doi.org/10.6084/m9.figshare.20376444.v1</ext-link>). Microarray data was deposited in the Gene Expression Omnibus (GEO) database under access code GSE199998 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE199998">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE199998</ext-link>).</p><p>The following datasets were generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>Assis</surname><given-names>Lde</given-names></name><name><surname>Harder</surname><given-names>L</given-names></name><name><surname>Oster</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementation</data-title><source>figshare</source><pub-id pub-id-type="doi">10.6084/m9.figshare.20376444.v1</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset2"><person-group person-group-type="author"><name><surname>Assis</surname><given-names>Lde</given-names></name><name><surname>Harder</surname><given-names>L</given-names></name><name><surname>Oster</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementation</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE199998">GSE199998</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>This work was supported by grants from the German Research Foundation (DFG) to HO 353-10/1, GRK-1957, and CRC-296 'LocoTact' (TP13 and TP14). JTH is a fellow of the São Paulo Research Foundation (FAPESP-04524-8/2020). We thank Lucas Moreira Ribeiro, the Federal University of Ouro Preto (UFOP, Brazil), for technical assistance in the bioinformatics analyses.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bargi-Souza</surname><given-names>P</given-names></name><name><surname>Goulart-Silva</surname><given-names>F</given-names></name><name><surname>Nunes</surname><given-names>MT</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Novel aspects of T<sub>3</sub> actions on GH and TSH synthesis and secretion: physiological implications</article-title><source>Journal of Molecular Endocrinology</source><volume>59</volume><fpage>R167</fpage><lpage>R178</lpage><pub-id pub-id-type="doi">10.1530/JME-17-0068</pub-id><pub-id pub-id-type="pmid">28951438</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonde</surname><given-names>Y</given-names></name><name><surname>Plösch</surname><given-names>T</given-names></name><name><surname>Kuipers</surname><given-names>F</given-names></name><name><surname>Angelin</surname><given-names>B</given-names></name><name><surname>Rudling</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5/G8 complex</article-title><source>Hepatology</source><volume>56</volume><fpage>1828</fpage><lpage>1837</lpage><pub-id pub-id-type="doi">10.1002/hep.25861</pub-id><pub-id pub-id-type="pmid">22829162</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chadt</surname><given-names>A</given-names></name><name><surname>Al-Hasani</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease</article-title><source>Pflugers Archiv</source><volume>472</volume><fpage>1273</fpage><lpage>1298</lpage><pub-id pub-id-type="doi">10.1007/s00424-020-02417-x</pub-id><pub-id pub-id-type="pmid">32591906</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cioffi</surname><given-names>F</given-names></name><name><surname>Zambad</surname><given-names>SP</given-names></name><name><surname>Chhipa</surname><given-names>L</given-names></name><name><surname>Senese</surname><given-names>R</given-names></name><name><surname>Busiello</surname><given-names>RA</given-names></name><name><surname>Tuli</surname><given-names>D</given-names></name><name><surname>Munshi</surname><given-names>S</given-names></name><name><surname>Moreno</surname><given-names>M</given-names></name><name><surname>Lombardi</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>RC</given-names></name><name><surname>Chauthaiwale</surname><given-names>V</given-names></name><name><surname>Dutt</surname><given-names>C</given-names></name><name><surname>de Lange</surname><given-names>P</given-names></name><name><surname>Silvestri</surname><given-names>E</given-names></name><name><surname>Lanni</surname><given-names>A</given-names></name><name><surname>Goglia</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>TRC150094, a novel functional analog of iodothyronines, reduces adiposity by increasing energy expenditure and fatty acid oxidation in rats receiving a high-fat diet</article-title><source>FASEB Journal</source><volume>24</volume><fpage>3451</fpage><lpage>3461</lpage><pub-id pub-id-type="doi">10.1096/fj.10-157115</pub-id><pub-id pub-id-type="pmid">20453112</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Assis</surname><given-names>LVM</given-names></name><name><surname>Oster</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The circadian clock and metabolic homeostasis: entangled networks</article-title><source>Cellular and Molecular Life Sciences</source><volume>78</volume><fpage>4563</fpage><lpage>4587</lpage><pub-id pub-id-type="doi">10.1007/s00018-021-03800-2</pub-id><pub-id pub-id-type="pmid">33683376</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Meltzer</surname><given-names>P</given-names></name><name><surname>Yen</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray</article-title><source>Molecular Endocrinology</source><volume>14</volume><fpage>947</fpage><lpage>955</lpage><pub-id pub-id-type="doi">10.1210/mend.14.7.0470</pub-id><pub-id pub-id-type="pmid">10894146</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flores-Morales</surname><given-names>A</given-names></name><name><surname>Gullberg</surname><given-names>H</given-names></name><name><surname>Fernandez</surname><given-names>L</given-names></name><name><surname>Ståhlberg</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>NH</given-names></name><name><surname>Vennström</surname><given-names>B</given-names></name><name><surname>Norstedt</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Patterns of liver gene expression governed by TRbeta</article-title><source>Molecular Endocrinology</source><volume>16</volume><fpage>1257</fpage><lpage>1268</lpage><pub-id pub-id-type="doi">10.1210/mend.16.6.0846</pub-id><pub-id pub-id-type="pmid">12040013</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>RG</given-names></name><name><surname>Hughes</surname><given-names>S</given-names></name><name><surname>Peirson</surname><given-names>SN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Circadian photoentrainment in mice and humans</article-title><source>Biology</source><volume>9</volume><elocation-id>E180</elocation-id><pub-id pub-id-type="doi">10.3390/biology9070180</pub-id><pub-id pub-id-type="pmid">32708259</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebhard</surname><given-names>RL</given-names></name><name><surname>Prigge</surname><given-names>WF</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Thyroid hormone differentially augments biliary sterol secretion in the rat. II. The chronic bile fistula model</article-title><source>Journal of Lipid Research</source><volume>33</volume><fpage>1467</fpage><lpage>1473</lpage><pub-id pub-id-type="doi">10.1016/S0022-2275(20)41401-4</pub-id><pub-id pub-id-type="pmid">1431571</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerhart-Hines</surname><given-names>Z</given-names></name><name><surname>Lazar</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Circadian metabolism in the light of evolution</article-title><source>Endocrine Reviews</source><volume>36</volume><fpage>289</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1210/er.2015-1007</pub-id><pub-id pub-id-type="pmid">25927923</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golombek</surname><given-names>DA</given-names></name><name><surname>Rosenstein</surname><given-names>RE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Physiology of circadian entrainment</article-title><source>Physiological Reviews</source><volume>90</volume><fpage>1063</fpage><lpage>1102</lpage><pub-id pub-id-type="doi">10.1152/physrev.00009.2009</pub-id><pub-id pub-id-type="pmid">20664079</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greco</surname><given-names>CM</given-names></name><name><surname>Koronowski</surname><given-names>KB</given-names></name><name><surname>Smith</surname><given-names>JG</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Kunderfranco</surname><given-names>P</given-names></name><name><surname>Carriero</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Samad</surname><given-names>M</given-names></name><name><surname>Welz</surname><given-names>PS</given-names></name><name><surname>Zinna</surname><given-names>VM</given-names></name><name><surname>Mortimer</surname><given-names>T</given-names></name><name><surname>Chun</surname><given-names>SK</given-names></name><name><surname>Shimaji</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>T</given-names></name><name><surname>Petrus</surname><given-names>P</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name><name><surname>Vaca-Dempere</surname><given-names>M</given-names></name><name><surname>Deryagin</surname><given-names>O</given-names></name><name><surname>Van</surname><given-names>C</given-names></name><name><surname>Kuhn</surname><given-names>JMM</given-names></name><name><surname>Lutter</surname><given-names>D</given-names></name><name><surname>Seldin</surname><given-names>MM</given-names></name><name><surname>Masri</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Baldi</surname><given-names>P</given-names></name><name><surname>Dyar</surname><given-names>KA</given-names></name><name><surname>Muñoz-Cánoves</surname><given-names>P</given-names></name><name><surname>Benitah</surname><given-names>SA</given-names></name><name><surname>Sassone-Corsi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Integration of feeding behavior by the liver circadian clock reveals network dependency of metabolic rhythms</article-title><source>Science Advances</source><volume>7</volume><elocation-id>eabi7828</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.abi7828</pub-id><pub-id pub-id-type="pmid">34550736</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heldmaier</surname><given-names>G</given-names></name></person-group><year iso-8601-date="1975">1975</year><article-title>Metabolic and thermoregulatory responses to heat and cold in the Djungarian hamster,Phodopus sungorus</article-title><source>Journal of Comparative Physiology ? B</source><volume>102</volume><fpage>115</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1007/BF00691297</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>DW</given-names></name><name><surname>Sherman</surname><given-names>BT</given-names></name><name><surname>Lempicki</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title><source>Nature Protocols</source><volume>4</volume><fpage>44</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>ME</given-names></name><name><surname>Hogenesch</surname><given-names>JB</given-names></name><name><surname>Kornacker</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>JTK_CYCLE: an efficient nonparametric algorithm for detecting rhythmic components in genome-scale data sets</article-title><source>Journal of Biological Rhythms</source><volume>25</volume><fpage>372</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1177/0748730410379711</pub-id><pub-id pub-id-type="pmid">20876817</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>S</given-names></name><name><surname>Jagannath</surname><given-names>A</given-names></name><name><surname>Rodgers</surname><given-names>J</given-names></name><name><surname>Hankins</surname><given-names>MW</given-names></name><name><surname>Peirson</surname><given-names>SN</given-names></name><name><surname>Foster</surname><given-names>RG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Signalling by melanopsin (OPN4) expressing photosensitive retinal ganglion cells</article-title><source>Eye</source><volume>30</volume><fpage>247</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1038/eye.2015.264</pub-id><pub-id pub-id-type="pmid">26768919</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husse</surname><given-names>J</given-names></name><name><surname>Eichele</surname><given-names>G</given-names></name><name><surname>Oster</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Synchronization of the mammalian circadian timing system: Light can control peripheral clocks independently of the SCN clock: alternate routes of entrainment optimize the alignment of the body’s circadian clock network with external time</article-title><source>BioEssays</source><volume>37</volume><fpage>1119</fpage><lpage>1128</lpage><pub-id pub-id-type="doi">10.1002/bies.201500026</pub-id><pub-id pub-id-type="pmid">26252253</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikegami</surname><given-names>K</given-names></name><name><surname>Refetoff</surname><given-names>S</given-names></name><name><surname>Van Cauter</surname><given-names>E</given-names></name><name><surname>Yoshimura</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Interconnection between circadian clocks and thyroid function</article-title><source>Nature Reviews. Endocrinology</source><volume>15</volume><fpage>590</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1038/s41574-019-0237-z</pub-id><pub-id pub-id-type="pmid">31406343</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johann</surname><given-names>K</given-names></name><name><surname>Cremer</surname><given-names>AL</given-names></name><name><surname>Fischer</surname><given-names>AW</given-names></name><name><surname>Heine</surname><given-names>M</given-names></name><name><surname>Pensado</surname><given-names>ER</given-names></name><name><surname>Resch</surname><given-names>J</given-names></name><name><surname>Nock</surname><given-names>S</given-names></name><name><surname>Virtue</surname><given-names>S</given-names></name><name><surname>Harder</surname><given-names>L</given-names></name><name><surname>Oelkrug</surname><given-names>R</given-names></name><name><surname>Astiz</surname><given-names>M</given-names></name><name><surname>Brabant</surname><given-names>G</given-names></name><name><surname>Warner</surname><given-names>A</given-names></name><name><surname>Vidal-Puig</surname><given-names>A</given-names></name><name><surname>Oster</surname><given-names>H</given-names></name><name><surname>Boelen</surname><given-names>A</given-names></name><name><surname>López</surname><given-names>M</given-names></name><name><surname>Heeren</surname><given-names>J</given-names></name><name><surname>Dalley</surname><given-names>JW</given-names></name><name><surname>Backes</surname><given-names>H</given-names></name><name><surname>Mittag</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Thyroid-hormone-induced browning of white adipose tissue does not contribute to thermogenesis and glucose consumption</article-title><source>Cell Reports</source><volume>27</volume><fpage>3385</fpage><lpage>3400</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2019.05.054</pub-id><pub-id pub-id-type="pmid">31189119</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonas</surname><given-names>W</given-names></name><name><surname>Lietzow</surname><given-names>J</given-names></name><name><surname>Wohlgemuth</surname><given-names>F</given-names></name><name><surname>Hoefig</surname><given-names>CS</given-names></name><name><surname>Wiedmer</surname><given-names>P</given-names></name><name><surname>Schweizer</surname><given-names>U</given-names></name><name><surname>Köhrle</surname><given-names>J</given-names></name><name><surname>Schürmann</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>3,5-Diiodo-L-thyronine (3,5-t2) exerts thyromimetic effects on hypothalamus-pituitary-thyroid axis, body composition, and energy metabolism in male diet-induced obese mice</article-title><source>Endocrinology</source><volume>156</volume><fpage>389</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1210/en.2014-1604</pub-id><pub-id pub-id-type="pmid">25322465</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaspari</surname><given-names>RR</given-names></name><name><surname>Reyna-Neyra</surname><given-names>A</given-names></name><name><surname>Jung</surname><given-names>L</given-names></name><name><surname>Torres-Manzo</surname><given-names>AP</given-names></name><name><surname>Hirabara</surname><given-names>SM</given-names></name><name><surname>Carrasco</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The paradoxical lean phenotype of hypothyroid mice is marked by increased adaptive thermogenesis in the skeletal muscle</article-title><source>PNAS</source><volume>117</volume><fpage>22544</fpage><lpage>22551</lpage><pub-id pub-id-type="doi">10.1073/pnas.2008919117</pub-id><pub-id pub-id-type="pmid">32826330</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowalik</surname><given-names>MA</given-names></name><name><surname>Columbano</surname><given-names>A</given-names></name><name><surname>Perra</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease</article-title><source>Frontiers in Endocrinology</source><volume>9</volume><elocation-id>382</elocation-id><pub-id pub-id-type="doi">10.3389/fendo.2018.00382</pub-id><pub-id pub-id-type="pmid">30042736</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ksendzovsky</surname><given-names>A</given-names></name><name><surname>Pomeraniec</surname><given-names>IJ</given-names></name><name><surname>Zaghloul</surname><given-names>KA</given-names></name><name><surname>Provencio</surname><given-names>JJ</given-names></name><name><surname>Provencio</surname><given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Clinical implications of the melanopsin-based non-image-forming visual system</article-title><source>Neurology</source><volume>88</volume><fpage>1282</fpage><lpage>1290</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000003761</pub-id><pub-id pub-id-type="pmid">28251921</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanni</surname><given-names>A</given-names></name><name><surname>Moreno</surname><given-names>M</given-names></name><name><surname>Lombardi</surname><given-names>A</given-names></name><name><surname>de Lange</surname><given-names>P</given-names></name><name><surname>Silvestri</surname><given-names>E</given-names></name><name><surname>Ragni</surname><given-names>M</given-names></name><name><surname>Farina</surname><given-names>P</given-names></name><name><surname>Baccari</surname><given-names>GC</given-names></name><name><surname>Fallahi</surname><given-names>P</given-names></name><name><surname>Antonelli</surname><given-names>A</given-names></name><name><surname>Goglia</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats</article-title><source>FASEB Journal</source><volume>19</volume><fpage>1552</fpage><lpage>1554</lpage><pub-id pub-id-type="doi">10.1096/fj.05-3977fje</pub-id><pub-id pub-id-type="pmid">16014396</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marjot</surname><given-names>T</given-names></name><name><surname>Ray</surname><given-names>DW</given-names></name><name><surname>Tomlinson</surname><given-names>JW</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Is it time for chronopharmacology in NASH?</article-title><source>Journal of Hepatology</source><volume>76</volume><fpage>1215</fpage><lpage>1224</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2021.12.039</pub-id><pub-id pub-id-type="pmid">35066087</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullur</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>YY</given-names></name><name><surname>Brent</surname><given-names>GA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Thyroid hormone regulation of metabolism</article-title><source>Physiological Reviews</source><volume>94</volume><fpage>355</fpage><lpage>382</lpage><pub-id pub-id-type="doi">10.1152/physrev.00030.2013</pub-id><pub-id pub-id-type="pmid">24692351</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname><given-names>R</given-names></name><name><surname>Parsons</surname><given-names>R</given-names></name><name><surname>Garner</surname><given-names>N</given-names></name><name><surname>Oster</surname><given-names>H</given-names></name><name><surname>Rawashdeh</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>CircaCompare: a method to estimate and statistically support differences in mesor, amplitude and phase, between circadian rhythms</article-title><source>Bioinformatics</source><volume>36</volume><fpage>1208</fpage><lpage>1212</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btz730</pub-id><pub-id pub-id-type="pmid">31588519</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philippe</surname><given-names>J</given-names></name><name><surname>Dibner</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Thyroid circadian timing: roles in physiology and thyroid malignancies</article-title><source>Journal of Biological Rhythms</source><volume>30</volume><fpage>76</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1177/0748730414557634</pub-id><pub-id pub-id-type="pmid">25411240</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pilorz</surname><given-names>V</given-names></name><name><surname>Astiz</surname><given-names>M</given-names></name><name><surname>Heinen</surname><given-names>KO</given-names></name><name><surname>Rawashdeh</surname><given-names>O</given-names></name><name><surname>Oster</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>The concept of coupling in the mammalian circadian clock network</article-title><source>Journal of Molecular Biology</source><volume>432</volume><fpage>3618</fpage><lpage>3638</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2019.12.037</pub-id><pub-id pub-id-type="pmid">31926953</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potter</surname><given-names>GDM</given-names></name><name><surname>Skene</surname><given-names>DJ</given-names></name><name><surname>Arendt</surname><given-names>J</given-names></name><name><surname>Cade</surname><given-names>JE</given-names></name><name><surname>Grant</surname><given-names>PJ</given-names></name><name><surname>Hardie</surname><given-names>LJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Circadian rhythm and sleep disruption: causes, metabolic consequences, and countermeasures</article-title><source>Endocrine Reviews</source><volume>37</volume><fpage>584</fpage><lpage>608</lpage><pub-id pub-id-type="doi">10.1210/er.2016-1083</pub-id><pub-id pub-id-type="pmid">27763782</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritter</surname><given-names>MJ</given-names></name><name><surname>Amano</surname><given-names>I</given-names></name><name><surname>Hollenberg</surname><given-names>AN</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Thyroid hormone signaling and the liver</article-title><source>Hepatology</source><volume>72</volume><fpage>742</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.1002/hep.31296</pub-id><pub-id pub-id-type="pmid">32343421</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>W</given-names></name><name><surname>Harrison</surname><given-names>RF</given-names></name><name><surname>Smith</surname><given-names>N</given-names></name><name><surname>Darzy</surname><given-names>K</given-names></name><name><surname>Shalet</surname><given-names>S</given-names></name><name><surname>Weetman</surname><given-names>AP</given-names></name><name><surname>Ross</surname><given-names>RJ</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Free triiodothyronine has a distinct circadian rhythm that is delayed but parallels thyrotropin levels</article-title><source>The Journal of Clinical Endocrinology and Metabolism</source><volume>93</volume><fpage>2300</fpage><lpage>2306</lpage><pub-id pub-id-type="doi">10.1210/jc.2007-2674</pub-id><pub-id pub-id-type="pmid">18364382</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Safran</surname><given-names>M</given-names></name><name><surname>Dalah</surname><given-names>I</given-names></name><name><surname>Alexander</surname><given-names>J</given-names></name><name><surname>Rosen</surname><given-names>N</given-names></name><name><surname>Iny Stein</surname><given-names>T</given-names></name><name><surname>Shmoish</surname><given-names>M</given-names></name><name><surname>Nativ</surname><given-names>N</given-names></name><name><surname>Bahir</surname><given-names>I</given-names></name><name><surname>Doniger</surname><given-names>T</given-names></name><name><surname>Krug</surname><given-names>H</given-names></name><name><surname>Sirota-Madi</surname><given-names>A</given-names></name><name><surname>Olender</surname><given-names>T</given-names></name><name><surname>Golan</surname><given-names>Y</given-names></name><name><surname>Stelzer</surname><given-names>G</given-names></name><name><surname>Harel</surname><given-names>A</given-names></name><name><surname>Lancet</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>GeneCards Version 3: the human gene integrator</article-title><source>Database</source><volume>2010</volume><elocation-id>baq020</elocation-id><pub-id pub-id-type="doi">10.1093/database/baq020</pub-id><pub-id pub-id-type="pmid">20689021</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>RA</given-names></name><name><surname>Singh</surname><given-names>BK</given-names></name><name><surname>Yen</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Thyroid hormone regulation of hepatic lipid and carbohydrate metabolism</article-title><source>Trends in Endocrinology and Metabolism</source><volume>25</volume><fpage>538</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1016/j.tem.2014.07.001</pub-id><pub-id pub-id-type="pmid">25127738</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>RA</given-names></name><name><surname>Singh</surname><given-names>BK</given-names></name><name><surname>Yen</surname><given-names>PM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Direct effects of thyroid hormones on hepatic lipid metabolism</article-title><source>Nature Reviews. Endocrinology</source><volume>14</volume><fpage>259</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2018.10</pub-id><pub-id pub-id-type="pmid">29472712</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sjögren</surname><given-names>M</given-names></name><name><surname>Alkemade</surname><given-names>A</given-names></name><name><surname>Mittag</surname><given-names>J</given-names></name><name><surname>Nordström</surname><given-names>K</given-names></name><name><surname>Katz</surname><given-names>A</given-names></name><name><surname>Rozell</surname><given-names>B</given-names></name><name><surname>Westerblad</surname><given-names>H</given-names></name><name><surname>Arner</surname><given-names>A</given-names></name><name><surname>Vennström</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Hypermetabolism in mice caused by the central action of an unliganded thyroid hormone receptor alpha1</article-title><source>The EMBO Journal</source><volume>26</volume><fpage>4535</fpage><lpage>4545</lpage><pub-id pub-id-type="doi">10.1038/sj.emboj.7601882</pub-id><pub-id pub-id-type="pmid">17932484</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Streckfuss</surname><given-names>F</given-names></name><name><surname>Hamann</surname><given-names>I</given-names></name><name><surname>Schomburg</surname><given-names>L</given-names></name><name><surname>Michaelis</surname><given-names>M</given-names></name><name><surname>Sapin</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>MO</given-names></name><name><surname>Köhrle</surname><given-names>J</given-names></name><name><surname>Schweizer</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice</article-title><source>Biochemical and Biophysical Research Communications</source><volume>337</volume><fpage>739</fpage><lpage>745</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2005.09.102</pub-id><pub-id pub-id-type="pmid">16202981</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Supek</surname><given-names>F</given-names></name><name><surname>Bošnjak</surname><given-names>M</given-names></name><name><surname>Škunca</surname><given-names>N</given-names></name><name><surname>Šmuc</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>REVIGO summarizes and visualizes long lists of gene ontology terms</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e21800</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0021800</pub-id><pub-id pub-id-type="pmid">21789182</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>JS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Transcriptional architecture of the mammalian circadian clock</article-title><source>Nature Reviews. Genetics</source><volume>18</volume><fpage>164</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1038/nrg.2016.150</pub-id><pub-id pub-id-type="pmid">27990019</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tschöp</surname><given-names>MH</given-names></name><name><surname>Speakman</surname><given-names>JR</given-names></name><name><surname>Arch</surname><given-names>JRS</given-names></name><name><surname>Auwerx</surname><given-names>J</given-names></name><name><surname>Brüning</surname><given-names>JC</given-names></name><name><surname>Chan</surname><given-names>L</given-names></name><name><surname>Eckel</surname><given-names>RH</given-names></name><name><surname>Farese</surname><given-names>RV</given-names></name><name><surname>Galgani</surname><given-names>JE</given-names></name><name><surname>Hambly</surname><given-names>C</given-names></name><name><surname>Herman</surname><given-names>MA</given-names></name><name><surname>Horvath</surname><given-names>TL</given-names></name><name><surname>Kahn</surname><given-names>BB</given-names></name><name><surname>Kozma</surname><given-names>SC</given-names></name><name><surname>Maratos-Flier</surname><given-names>E</given-names></name><name><surname>Müller</surname><given-names>TD</given-names></name><name><surname>Münzberg</surname><given-names>H</given-names></name><name><surname>Pfluger</surname><given-names>PT</given-names></name><name><surname>Plum</surname><given-names>L</given-names></name><name><surname>Reitman</surname><given-names>ML</given-names></name><name><surname>Rahmouni</surname><given-names>K</given-names></name><name><surname>Shulman</surname><given-names>GI</given-names></name><name><surname>Thomas</surname><given-names>G</given-names></name><name><surname>Kahn</surname><given-names>CR</given-names></name><name><surname>Ravussin</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A guide to analysis of mouse energy metabolism</article-title><source>Nature Methods</source><volume>9</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1806</pub-id><pub-id pub-id-type="pmid">22205519</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vujovic</surname><given-names>M</given-names></name><name><surname>Dudazy-Gralla</surname><given-names>S</given-names></name><name><surname>Hård</surname><given-names>J</given-names></name><name><surname>Solsjö</surname><given-names>P</given-names></name><name><surname>Warner</surname><given-names>A</given-names></name><name><surname>Vennström</surname><given-names>B</given-names></name><name><surname>Mittag</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Thyroid hormone drives the expression of mouse carbonic anhydrase Car4 in kidney, lung and brain</article-title><source>Molecular and Cellular Endocrinology</source><volume>416</volume><fpage>19</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2015.08.017</pub-id><pub-id pub-id-type="pmid">26319697</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weeke</surname><given-names>J</given-names></name><name><surname>Laurberg</surname><given-names>P</given-names></name></person-group><year iso-8601-date="1980">1980</year><article-title>24-h profile of serum rT3 and serum 3,3’-T2 in normal man</article-title><source>Acta Endocrinologica</source><volume>94</volume><fpage>503</fpage><lpage>506</lpage><pub-id pub-id-type="doi">10.1530/acta.0.0940503</pub-id><pub-id pub-id-type="pmid">7192042</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname><given-names>AC</given-names></name><name><surname>Bechtold</surname><given-names>DA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The cost of circadian desynchrony: Evidence, insights and open questions</article-title><source>BioEssays</source><volume>37</volume><fpage>777</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1002/bies.201400173</pub-id><pub-id pub-id-type="pmid">26010005</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Anafi</surname><given-names>RC</given-names></name><name><surname>Hughes</surname><given-names>ME</given-names></name><name><surname>Kornacker</surname><given-names>K</given-names></name><name><surname>Hogenesch</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>MetaCycle: an integrated R package to evaluate periodicity in large scale data</article-title><source>Bioinformatics</source><volume>32</volume><fpage>3351</fpage><lpage>3353</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw405</pub-id><pub-id pub-id-type="pmid">27378304</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zavacki</surname><given-names>AM</given-names></name><name><surname>Ying</surname><given-names>H</given-names></name><name><surname>Christoffolete</surname><given-names>MA</given-names></name><name><surname>Aerts</surname><given-names>G</given-names></name><name><surname>So</surname><given-names>E</given-names></name><name><surname>Harney</surname><given-names>JW</given-names></name><name><surname>Cheng</surname><given-names>SY</given-names></name><name><surname>Larsen</surname><given-names>PR</given-names></name><name><surname>Bianco</surname><given-names>AC</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse</article-title><source>Endocrinology</source><volume>146</volume><fpage>1568</fpage><lpage>1575</lpage><pub-id pub-id-type="doi">10.1210/en.2004-1392</pub-id><pub-id pub-id-type="pmid">15591136</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Lahens</surname><given-names>NF</given-names></name><name><surname>Ballance</surname><given-names>HI</given-names></name><name><surname>Hughes</surname><given-names>ME</given-names></name><name><surname>Hogenesch</surname><given-names>JB</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>A circadian gene expression atlas in mammals: implications for biology and medicine</article-title><source>PNAS</source><volume>111</volume><fpage>16219</fpage><lpage>16224</lpage><pub-id pub-id-type="doi">10.1073/pnas.1408886111</pub-id><pub-id pub-id-type="pmid">25349387</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Hulver</surname><given-names>MW</given-names></name><name><surname>McMillan</surname><given-names>RP</given-names></name><name><surname>Cline</surname><given-names>MA</given-names></name><name><surname>Gilbert</surname><given-names>ER</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility</article-title><source>Nutrition &amp; Metabolism</source><volume>11</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.1186/1743-7075-11-10</pub-id><pub-id pub-id-type="pmid">24520982</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Xie</surname><given-names>H</given-names></name><name><surname>Shan</surname><given-names>H</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Development of thyroid hormones and synthetic thyromimetics in non-alcoholic fatty liver disease</article-title><source>International Journal of Molecular Sciences</source><volume>23</volume><elocation-id>1102</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23031102</pub-id><pub-id pub-id-type="pmid">35163026</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.79405.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Quinn</surname><given-names>Matthew A</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Wake Forest School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.04.28.489909" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.04.28.489909"/></front-stub><body><p>de Assis et al. demonstrate a role for T3 in modulating circadian metabolic rhythms both systemically and within the liver. The findings extend the molecular framework in which organismal metabolism is coordinated in a circadian fashion.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.79405.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Quinn</surname><given-names>Matthew A</given-names></name><role>Reviewing Editor</role><aff><institution>Wake Forest School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Dibner</surname><given-names>Charna</given-names></name><role>Reviewer</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01swzsf04</institution-id><institution>University of Geneva</institution></institution-wrap><country>Switzerland</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.04.28.489909">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.04.28.489909v1">the preprint</ext-link> for the benefit of readers; ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementation&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by a Reviewing Editor and Mone Zaidi as the Senior Editor. The following individual involved in the review of your submission has agreed to reveal their identity: Charna Dibner (Reviewer #2).</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1) The authors claim on lines 118-121 that control mice show diurnal regulation of T3 levels in Figure 1 A. Furthermore, the authors claim T3 supplemented mice show no diurnal regulation. Figure 1A shows in fact that control mice show low T3 levels with no diurnal regulation while T3 supplemented mice show robust diurnal levels of T3. The data do not support the authors' claims and this needs to be addressed.</p><p>2) In Figure 1G-O the authors try to determine if there is a correlation between T3 levels and metabolic parameters. They claim that T3 levels were strongly associated with body temperature and V02 (Figure 1H-I). However, when actual T3 levels were correlated with metabolic parameters (Figure 1J-O) there are no correlations that exist. Once again, the author's claims do not seem to be supported by the data presented. This needs to be clarified how their interpretation of this data was derived.</p><p>3) The author's claim to &quot;Comparing the liver transcriptome across times of day and T3 treatment conditions&quot;. However, the volcano plot in Figure 2A does not represent a continuum of time. It only shows genes up or down in response to T3 treatment. The time of day that was analyzed is needed for clarification for this figure.</p><p>4) In clinical hyperthyroidism, both T3 and T4 are elevated along with decreased TSH levels. It might be helpful to bring up in the Discussion chapter the feedback inhibition of TSH and T4 production upon T3 treatment in the mouse model. Given that T4 is converted into T3 mainly in the liver, the decrease in the substrate (T4) may impact the converting enzyme system (notably, Dio1) in the liver. Did the authors observe these changes in the Deiodinases transcript levels? This point also might be included in the discussion.</p><p>5) In Figure 3, There is a weak phase shift in clock gene expression by T3. However, the effect of such change was not observed in other parameters. What is the significance of such changes? The authors should address this within the results or discussion.</p><p><italic>Reviewer #1 (Recommendations for the authors):</italic></p><p>The authors do an elegant job of assessing their goals through comprehensive metabolic and transcriptional profiling. While the authors provide novel insight into the role of T3 in modulating circadian metabolism, both major and minor points arose during the review of this manuscript described below:</p><p>1. The authors provide a rich interpretation of their data within the discussion. However, the physiological and clinical relevance of their studies needs to be enhanced. I still have not garnered the importance of these studies and how the field of thyroid disorders is enhanced. This needs to be addressed within the discussion.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.79405.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) The authors claim on lines 118-121 that control mice show diurnal regulation of T3 levels in Figure 1 A. Furthermore, the authors claim T3 supplemented mice show no diurnal regulation. Figure 1A shows in fact that control mice show low T3 levels with no diurnal regulation while T3 supplemented mice show robust diurnal levels of T3. The data do not support the authors' claims and this needs to be addressed.</p></disp-quote><p>We would like to clarify that this apparent discrepancy was contributed by the y-axis scaling. Indeed, in CON group, T<sub>3</sub> levels are rhythmic (with a period of 24 h), but with a small amplitude. On the other hand, in the T<sub>3</sub>-treated group, T<sub>3</sub> levels show variations over the course of the day, but with two peaks (around the early morning and early night). Therefore, they are not classified as circadian (i.e., with a period of ca. 24 h), but are considered ultradian according to JTK cycle (Table S1, period of 12h, p = 0.01). In the revised version, a new scaling was introduced, and graphs were double plotted to facilitate visualization. The temporal variations in T<sub>3</sub> levels were acknowledged.</p><p>Line 121 – 124: “However, T3 levels showed a temporal variation (ANOVA, p = 0.006), which classified as ultradian by JTK cycle (12 h period length, Supplementary File 1, p = 0.01) in the T3 treated group. T4 levels were non-rhythmic in all groups (Figure 1A – B, Supplementary File 1).”.</p><disp-quote content-type="editor-comment"><p>2) In Figure 1G-O the authors try to determine if there is a correlation between T3 levels and metabolic parameters. They claim that T3 levels were strongly associated with body temperature and V02 (Figure 1H-I). However, when actual T3 levels were correlated with metabolic parameters (Figure 1J-O) there are no correlations that exist. Once again, the author's claims do not seem to be supported by the data presented. This needs to be clarified how their interpretation of this data was derived.</p></disp-quote><p>Our goal was to distinguish to which extent T<sub>3</sub> could serve as long-term marker (<italic>trait effect</italic>) and as an acute (“temporal”) marker (<italic>state effect</italic>) of energy metabolism. For the first approach, we compared activity, temperature, and VO<sub>2</sub> data between the two different T3 conditions. These data indicate that elevation of T3 levels correlates with increased energy turnover in the long run. For the temporal comparison we correlated T3 levels and metabolic parameters at different times of day. To make these differences comparable across the two treatment groups (i.e., to account for trait effects), we normalized all data (T3 and metabolic parameters) to the daily average. Here, all correlative effects are lost. Thus, T3 levels do not predict metabolic activity at any specific time of the day. In other words, T3 is not a <italic>temporal metabolic marker</italic> (Table S2). We think this distinction is very relevant for the field.</p><p>We agree with the reviewer’s criticism and in this revised version, the average graphs were removed. We now plot T3 average levels against the metabolic outputs and then a linear regression is performed. In this approach, we could see that average T3 levels correlate with body temperature and VO2.</p><p>Line 152 – 156: “Correlating the average levels of T3 against activity, body temperature, and VO2, revealed that body temperature and VO2 were positively correlated with T3 levels (Figure 1G – I). TH levels and metabolic parameters, however, did not correlate across daytime. Therefore, neither T3 nor T4 qualified as markers for diurnal variations in energy metabolism (Figure 1J – O, Supplementary File 2).</p><disp-quote content-type="editor-comment"><p>3) The author's claim to &quot;Comparing the liver transcriptome across times of day and T3 treatment conditions&quot;. However, the volcano plot in Figure 2A does not represent a continuum of time. It only shows genes up or down in response to T3 treatment. The time of day that was analyzed is needed for clarification for this figure.</p></disp-quote><p>In the original version, this sentence was meant to indicate that we combined all timepoints and made a global analysis of the DEGs. We have amended the sentence in the revision.</p><p>Line 165 – 167: “Comparing the liver transcriptome, without taking into consideration the sampling time, 2,343 differentially expressed probe sets (2,336 genes – DEGs) were identified (± 1.5-fold change; FDR &lt; 0.1; Figure 2A, Supplementary File 3).”</p><disp-quote content-type="editor-comment"><p>4) In clinical hyperthyroidism, both T3 and T4 are elevated along with decreased TSH levels. It might be helpful to bring up in the Discussion chapter the feedback inhibition of TSH and T4 production upon T3 treatment in the mouse model. Given that T4 is converted into T3 mainly in the liver, the decrease in the substrate (T4) may impact the converting enzyme system (notably, Dio1) in the liver. Did the authors observe these changes in the Deiodinases transcript levels? This point also might be included in the discussion.</p></disp-quote><p>Although T<sub>3</sub>-treated mice show classical effects of hyperthyroidism, the T<sub>4</sub> levels are severely downregulated. This marked reduction on T<sub>4</sub> level is known to happen in this experimental model and is fully acknowledged in our manuscript. Because of this, we avoided to call T<sub>3</sub> mie hyperthyroid, but rather we addressed them as T<sub>3</sub> high.</p><p><italic>Dio1</italic> expression was markedly increased by T<sub>3</sub> and is among the top 15 highly expressed genes in the global DEGs analysis (Table S3) and it was differentially expressed in every ZT, except in ZT 22 due to a technical variation (Table S4). We did not measure DIO activity, but it is conceivable that the upregulation of Dio1 expression reflects sensitization of the DIO system in the absence of T4. We acknowledged in the manuscript that, although we may see an upregulation of <italic>Dio1</italic>, it is known that this enzyme does not contribute to systemic levels of thyroid hormones, but rather displays an important local role in the liver.</p><p>Please find below the new incorporations made into the manuscript.</p><p>Line 321 – 327: “In the human hyperthyroidism condition, T<sub>3</sub> and T<sub>4</sub> serum levels are both elevated while TSH levels are reduced as part of the inhibitory feedback mechanism of T<sub>3</sub> on TSH secretion. In our experimental model, providing T<sub>3</sub> levels in the drinking water resulted in the activation of TH effects in the liver, but T<sub>4</sub> levels – and, likely, TSH – were reduced, as had previously been reported for this experimental model (Johann et al., 2019). Again, this effect is easily explained by the negative feedback of T<sub>3</sub> on TSH – and, subsequently, T<sub>4</sub> – regulation. Based on this, we refer to our model as “T<sub>3</sub> high” instead of hyperthyroid.”</p><p>Line 382 – 386: “This finding may reflect an increased need for T<sub>3</sub> metabolization in the liver by DIO1. Although, we did not measure DIO1 activity, one could suggest that the observed <italic>Dio1</italic> mRNA upregulation reflects sensitization to a scenario where T<sub>4</sub> and T<sub>3</sub> are down- and upregulated, respectively. Indeed, DIO1’s contribution to thyroid state in the liver is critical while it has little effect on systemic thyroid hormone levels (Streckfuss et al., 2005).”</p><disp-quote content-type="editor-comment"><p>5) In Figure 3, There is a weak phase shift in clock gene expression by T3. However, the effect of such change was not observed in other parameters. What is the significance of such changes? The authors should address this within the results or discussion.</p></disp-quote><p>We suggest that T<sub>3</sub> has a slight, but consistent phase delay on the clock genes. A similar phase delay is found for the robustly rhythmic genes shared between CON and T<sub>3</sub> groups. The similarity between the phase delay averages might suggest that this is indeed a clock-regulated process. However, it would go beyond the scope of this paper to functionally test this assumption.</p><p>We have a statement in the discussion part.</p><p>Line 404 – 410: “In fact, the similarity in the phase delay between clock gene rhythms and those of robustly rhythmic genes suggests that the latter may indeed involve control through the liver clock. One potential mechanism could involve direct regulation of clock gene transcription by THRB. THRB binding sites are found in the promoter region of several clock genes such as <italic>Bmal1</italic>, <italic>Rev-erbα/β, Cry1/2</italic>, and <italic>Per1-3</italic> (GeneCards website, (Safran et al., 2010)). Further experimental studies are required to test this interaction of TH and clock function.”</p><disp-quote content-type="editor-comment"><p>Reviewer #1 (Recommendations for the authors):</p><p>The authors do an elegant job of assessing their goals through comprehensive metabolic and transcriptional profiling. While the authors provide novel insight into the role of T3 in modulating circadian metabolism, both major and minor points arose during the review of this manuscript described below:</p><p>1. The authors provide a rich interpretation of their data within the discussion. However, the physiological and clinical relevance of their studies needs to be enhanced. I still have not garnered the importance of these studies and how the field of thyroid disorders is enhanced. This needs to be addressed within the discussion.</p></disp-quote><p>We have improved this section in the manuscript.</p><p>Lines 481 – 493: “Our findings reveal a novel layer of regulation of TH action in the liver – and, potentially, in other tissues. As we have shown that high T3 disrupts the rhythmicity of important metabolic processes, this implies that the time of assessment of metabolic parameters in hyperthyroid (and, similarly, hypothyroid) patients should be taken into consideration. Another novel aspect of our findings is the role of liver circadian rhythms in modulating local thyroid hormone action itself. Such circadian gating might explain variances in the outcomes of T3 treatment if temporal aspects are not taken into consideration. Our data strongly argue for more temporal control in TH studies. Finally, considering that THs are major regulators of metabolism in the liver, therapies of metabolic pathologies could benefit from chronomodulated regimes. Modulation of TH action has been proposed for non-alcoholic fatty liver disease (NAFLD) treatment (Kowalik et al., 2018; Zhao et al., 2022), and our data may assist in the design of a time-of-day dependent drug regime for this approach (Marjot et al., 2022).</p></body></sub-article></article>